{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:04:41Z","timestamp":1755216281619,"version":"3.43.0"},"reference-count":246,"publisher":"Bentham Science Publishers Ltd.","issue":"30","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPD"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>SARS-CoV-2, the virus responsible for COVID-19, has resulted in a devastating global impact\nwith millions of lives lost. Remdesivir and 2-DG are among the few drugs authorized for emergency use\nagainst COVID-19, but concerns about their efficacy and side effects persist. Vaccines have been developed\nand approved, yet the emergence of viral mutations has raised questions about their effectiveness against new\nvariants. Natural compounds with antiviral properties have shown promise in combating SARS-CoV-2. The\nreview highlights the potential of medicinal plant compounds, particularly in targeting the virus' main protease,\na crucial component for viral replication. Natural, plant-derived compounds represent a promising avenue\nfor COVID-19 therapeutics. Further clinical validation is necessary to ascertain their efficacy and safety in\ntreating COVID-19. This underscores the importance of continued research into alternative treatments for\ncombating this global health crisis. This review examines the potential of natural, plant-derived compounds as\nsafe and cost-effective alternatives for combating COVID-19. It summarizes the pathogenesis of SARS-CoV-\n2 and the ongoing drug studies and identifies natural compounds with known antiviral properties. Additionally,\nit explores the potential of medicinal plant compounds in targeting the SARS-CoV-2 main protease\nthrough &lt;i&gt;in silico&lt;\/i&gt; and molecular docking studies.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0113816128344055250220100720","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T02:31:15Z","timestamp":1742437875000},"page":"2416-2437","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of Natural Compounds as Potential COVID-19 Main Protease (Mpro) Inhibitors: A Comprehensive Study and In silico Evidence"],"prefix":"10.2174","volume":"31","author":[{"given":"Arti","family":"Devi","sequence":"first","affiliation":[{"name":"University Institute of Biotechnology, Chandigarh University, Mohali, Punjab, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vagish","family":"Dwibedi","sequence":"additional","affiliation":[{"name":"University Institute of Biotechnology, Chandigarh University, Mohali, Punjab, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahil","family":"Jain","sequence":"additional","affiliation":[{"name":"University Institute of Biotechnology, Chandigarh University, Mohali, Punjab, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gursharan","family":"Kaur","sequence":"additional","affiliation":[{"name":"University Institute of Biotechnology, Chandigarh University, Mohali, Punjab, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaved Ahmed","family":"Khan","sequence":"additional","affiliation":[{"name":"Faculty of Life Sciences Baba Farid College,\nMuktsar Road, Bathinda, Punjab, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudip Kumar","family":"Mandal","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Dr. B. C. Roy College of Pharmacy and AHS,\nDurgapur, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditya","family":"Shiven","sequence":"additional","affiliation":[{"name":"University Institute of Pharma Sciences (UIPS), Chandigarh University NH-05 Chandigarh Ludhiana Highway,\nMohali Punjab 140413, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamal","family":"Shah","sequence":"additional","affiliation":[{"name":"University Institute of Pharma Sciences (UIPS), Chandigarh University NH-05 Chandigarh Ludhiana\nHighway, Mohali Punjab, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3440-1884","authenticated-orcid":true,"given":"Hitesh Kumar","family":"Dewangan","sequence":"additional","affiliation":[{"name":"University Institute of Pharma Sciences (UIPS), Chandigarh University NH-05 Chandigarh Ludhiana\nHighway, Mohali Punjab, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santosh Kumar","family":"Rath","sequence":"additional","affiliation":[{"name":"School of Pharmaceuticals and Population Health Informatics, Faculty of Pharmacy, DIT University,\nDehradun, Uttarakhand, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3906\/sag-2004-172","volume":"50","author":"Bulut C.","year":"2020","unstructured":"Bulut C.; Kato Y.; Epidemiology of COVID-19. Turk J Med Sci  2020,50(SI-1),563-570","journal-title":"Turk J Med Sci"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1017\/dmp.2020.235","volume":"15","author":"Sun Y.J.","year":"2021","unstructured":"Sun Y.J.; Feng Y.J.; Chen J.; Li B.; Luo Z.C.; Wang P.X.; Clinical features of fatalities in patients with COVID-19. Disaster Med Public Health Prep  2021,15(2),e9-e11","journal-title":"Disaster Med Public Health Prep"},{"year":"2022","key":"ref=3","unstructured":"WHO Director-General\u2019s opening remarks at the media briefing on COVID-19.  Available from:  https:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 (Accessed on: 11 March 2020).2022"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.1038\/s41598-023-30647-3","volume":"13","author":"Ullah R.","year":"2023","unstructured":"Ullah R.; Mdallal A.Q.; Khan T.; Ullah R.; Alwan A.B.; Faiz F.; Zhu Q.; The dynamics of novel corona virus disease via stochastic epidemiological model with vaccination. Sci Rep  2023,13(1),3805","journal-title":"Sci Rep"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1007\/s43678-022-00306-z","volume":"24","author":"Lavoie B.","year":"2022","unstructured":"Lavoie B.; Bourque C.J.; C\u00f4t\u00e9 A.J.; Rajagopal M.; Clerc P.; Bourdeau V.; Ali S.; Trottier D.E.; Castonguay V.; Pag\u00e9 F.\u00c9.; Burstein B.; Desaulniers P.; Goldman R.D.; Thompson G.; Berthelot S.; Lagac\u00e9 M.; Gaucher N.; The responsibility to care: Lessons learned from emergency department workers\u2019 perspectives during the first wave of the COVID-19 pandemic in Canada. CJEM  2022,24(5),482-492","journal-title":"CJEM"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41573-023-00672-y","volume":"22","author":"Li G.","year":"2023","unstructured":"Li G.; Hilgenfeld R.; Whitley R.; Clercq D.E.; Therapeutic strategies for COVID-19: Progress and lessons learned. Nat Rev Drug Discov  2023,22(6),449-475","journal-title":"Nat Rev Drug Discov"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12575-020-00128-2","volume":"22","author":"Esakandari H.","year":"2020","unstructured":"Esakandari H.; Afjadi N.M.; Afjadi F.J.; Farahmandian N.; Miresmaeili S.M.; Bahreini E.; A comprehensive review of COVID-19 characteristics. Biol Proced Online  2020,22(1),19","journal-title":"Biol Proced Online"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ijid.2020.03.004","volume":"94","author":"Wu D.","year":"2020","unstructured":"Wu D.; Wu T.; Liu Q.; Yang Z.; The SARS-CoV-2 outbreak: What we know. Int J Infect Dis  2020,94,44-48","journal-title":"Int J Infect Dis"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"102988","DOI":"10.1016\/j.jddst.2021.102988","volume":"67","author":"Dewangan H.K.","year":"2022","unstructured":"Dewangan H.K.; Tomar S.; Nanovaccine for transdermal delivery system. J Drug Deliv Sci Technol  2022,67,102988","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1007\/s40265-020-01421-w","volume":"80","author":"Cantini F.","year":"2020","unstructured":"Cantini F.; Goletti D.; Petrone L.; Fard N.S.; Niccoli L.; Foti R.; Immune therapy, or antiviral therapy, or both for COVID-19: A systematic review. Drugs  2020,80(18),1929-1946","journal-title":"Drugs"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.2174\/1567201815666180604110457","volume":"15","author":"Dewangan H.K.","year":"2018","unstructured":"Dewangan H.K.; Singh S.; Maurya L.; Srivastava A.; Hepatitis B.; Antigen loaded biodegradable polymeric nanoparticles: Formulation optimization and in-vivo immunization in BALB\/c mice. Curr Drug Deliv  2018,15(8),1204-1215","journal-title":"Curr Drug Deliv"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s40495-020-00216-7","volume":"6","author":"Wu R.","year":"2020","unstructured":"Wu R.; Wang L.; Kuo H.C.D.; Shannar A.; Peter R.; Chou P.J.; Li S.; Hudlikar R.; Liu X.; Liu Z.; Poiani G.J.; Amorosa L.; Brunetti L.; Kong A.N.; An update on current therapeutic drugs treating COVID-19. Curr Pharmacol Rep  2020,6(3),56-70","journal-title":"Curr Pharmacol Rep"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/B978-0-323-91172-6.00005-4","author":"Kumar A.","year":"2022","unstructured":"Kumar A.; Parihar A.; Basha S.N.; Panda U.; Clinically available\/under trial drugs and vaccines for treatment of SARS-COV-2. Computational Approaches for Novel Therapeutic and Diagnostic Designing to Mitigate SARS-CoV-2 Infection  2022,451-488","journal-title":"Computational Approaches for Novel Therapeutic and Diagnostic Designing to Mitigate SARS-CoV-2 Infection"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"837290","DOI":"10.3389\/fimmu.2022.837290","volume":"13","author":"Islam M.A.","year":"2022","unstructured":"Islam M.A.; Haque M.A.; Rahman M.A.; Hossen F.; Reza M.; Barua A.; Marzan A.A.; Das T.; Baral K.S.; He C.; Ahmed F.; Bhattacharya P.; Jakariya M.; A review on measures to rejuvenate immune system: natural mode of protection against coronavirus infection. Front Immunol  2022,13,837290","journal-title":"Front Immunol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"153286","DOI":"10.1016\/j.phymed.2020.153286","volume":"85","author":"Mhatre S.","year":"2021","unstructured":"Mhatre S.; Srivastava T.; Naik S.; Patravale V.; Antiviral activity of green tea and black tea polyphenols in prophylaxis and treatment of COVID-19: A review. Phytomedicine  2021,85,153286","journal-title":"Phytomedicine"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.apsb.2020.06.002","volume":"10","author":"Xian Y.","year":"2020","unstructured":"Xian Y.; Zhang J.; Bian Z.; Zhou H.; Zhang Z.; Lin Z.; Xu H.; Bioactive natural compounds against human coronaviruses: A review and perspective. Acta Pharm Sin B  2020,10(7),1163-1174","journal-title":"Acta Pharm Sin B"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.ijbiomac.2018.01.073","volume":"111","author":"Dewangan H.K.","year":"2018","unstructured":"Dewangan H.K.; Pandey T.; Maurya L.; Singh S.; Rational design and evaluation of HBsAg polymeric nanoparticles as antigen delivery carriers. Int J Biol Macromol  2018,111,804-812","journal-title":"Int J Biol Macromol"},{"key":"ref=18","first-page":"317","volume":"11","author":"Patnaik KC","year":"2020","unstructured":"Patnaik KC; Rajput D; Role of antioxidant herbs and yoga practices in prevention of infectious diseases with special reference to COVID-19 pandemic. Inter J Res Pharm Sci  2020,11,317-22","journal-title":"Inter J Res Pharm Sci"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3390\/medicina56080386","volume":"56","author":"Soto M.E.","year":"2020","unstructured":"Soto M.E.; Lans G.V.; Castro S.E.; Pech M.L.; Torres P.I.; Is antioxidant therapy a useful complementary measure for COVID-19 treatment? An algorithm for its application. Medicina  2020,56(8),386","journal-title":"Medicina"},{"key":"ref=20","first-page":"121","volume":"6","author":"Derouiche S.","year":"2020","unstructured":"Derouiche S.; Oxidative stress associated with SARS-Cov-2 (COVID-19) increases the severity of the lung disease-a systematic review. J Infect Dis Epidemiol  2020,6(3),121-126","journal-title":"J Infect Dis Epidemiol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"23379","DOI":"10.1039\/D0RA03774E","volume":"10","author":"Antonio A.S.","year":"2020","unstructured":"Antonio A.S.; Wiedemann L.S.M.; Junior V.V.F.; Natural products\u2019 role against COVID-19. RSC Advances  2020,10(39),23379-23393","journal-title":"RSC Advances"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"588508","DOI":"10.3389\/fphar.2020.588508","volume":"11","author":"Huang J.","year":"2020","unstructured":"Huang J.; Tao G.; Liu J.; Cai J.; Huang Z.; Chen J.; Current prevention of COVID-19: Natural products and herbal medicine. Front Pharmacol  2020,11,588508","journal-title":"Front Pharmacol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1080\/02652048.2022.2084169","volume":"39","author":"Raghuvanshi A.","year":"2022","unstructured":"Raghuvanshi A.; Shah K.; Dewangan H.K.; Ethosome as antigen delivery carrier: Optimisation, evaluation and induction of immunological response via nasal route against hepatitis B. J Microencapsul  2022,39(4),352-363","journal-title":"J Microencapsul"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/376327","volume":"2013","author":"Pandey M.M.","year":"2013","unstructured":"Pandey M.M.; Rastogi S.; Rawat A.K.S.; Indian traditional ayurvedic system of medicine and nutritional supplementation. Evid Based Complement Alternat Med  2013,2013(1),1-12","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jtcme.2016.02.002","volume":"7","author":"Jaiswal Y.S.","year":"2017","unstructured":"Jaiswal Y.S.; Williams L.L.; A glimpse of Ayurveda \u2013 The forgotten history and principles of Indian traditional medicine. J Tradit Complement Med  2017,7(1),50-53","journal-title":"J Tradit Complement Med"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1007\/s00253-022-11801-9","volume":"106","author":"Dwibedi V.","year":"2022","unstructured":"Dwibedi V.; Jain S.; Singhal D.; Mittal A.; Rath S.K.; Saxena S.; Inhibitory activities of grape bioactive compounds against enzymes linked with human diseases. Appl Microbiol Biotechnol  2022,106(4),1399-1417","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1089\/acm.2020.0129","volume":"26","author":"Tillu G.","year":"2020","unstructured":"Tillu G.; Chaturvedi S.; Chopra A.; Patwardhan B.; Public health approach of ayurveda and yoga for COVID-19 prophylaxis. J Altern Complement Med  2020,26(5),360-364","journal-title":"J Altern Complement Med"},{"key":"ref=28","first-page":"26","volume":"2","author":"Acharyya A.","year":"2020","unstructured":"Acharyya A.; Prospect of ayurveda system of medicine in recent COVID-19 pandemic in India. Int J Ayurv Tradit Medi  2020,2(2),26-29","journal-title":"Int J Ayurv Tradit Medi"},{"key":"ref=29","first-page":"1158","volume":"118","author":"Patwardhan B.","year":"2020","unstructured":"Patwardhan B.; Gautam C.P.; Gautam M.; Tillu G.; Chopra A.; Gairola S.; Jadhav S.; Ayurveda rasayana in prophylaxis of COVID-19. Curr Sci  2020,118(8),1158-1160","journal-title":"Curr Sci"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1002\/ptr.7019","volume":"35","author":"Singh N.A.","year":"2021","unstructured":"Singh N.A.; Kumar P.; Jyoti ; Kumar N.; Spices and herbs: Potential antiviral preventives and immunity boosters during COVID\u201019. Phytother Res  2021,35(5),2745-2757","journal-title":"Phytother Res"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s11655-020-2851-y","volume":"26","author":"Shankar A.","year":"2020","unstructured":"Shankar A.; Dubey A.; Saini D.; Prasad C.P.; Role of complementary and alternative medicine in prevention and treatment of COVID-19: An overhyped hope. Chin J Integr Med  2020,26(8),565-567","journal-title":"Chin J Integr Med"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"3442","DOI":"10.2174\/0113816128276948231204111531","volume":"29","author":"Marwah H.","year":"2023","unstructured":"Marwah H.; Pant J.; Yadav J.; Shah K.; Dewangan H.K.; Biosensor detection of COVID-19 in lung cancer: Hedgehog and Mucin signaling insights. Curr Pharm Des  2023,29(43),3442-3457","journal-title":"Curr Pharm Des"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1142\/S2737416524500066","volume":"23","author":"Dewangan H.K.","year":"2024","unstructured":"Dewangan H.K.; Shah K.; Sharma R.; Sharma S.; Kumar A.; Khan M.I.; Alghamdi A.A.; Abbas M.; Emerging trends on nano-vaccines administration and functionalization strategies for immunization. J Computat Biophys Chem  2024,23(5),575-604","journal-title":"J Computat Biophys Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"104146","DOI":"10.1016\/j.jff.2020.104146","volume":"73","author":"Chojnacka K.","year":"2020","unstructured":"Chojnacka K.; Krowiak W.A.; Skrzypczak D.; Mikula K.; M\u0142ynarz P.; Phytochemicals containing biologically active polyphenols as an effective agent against COVID-19-inducing coronavirus. J Funct Foods  2020,73,104146","journal-title":"J Funct Foods"},{"key":"ref=35","first-page":"26","volume":"3","author":"Renjith M.R.D.","year":"2020","unstructured":"Renjith M.R.D.; Sankar M.; Scope of phytochemicals in the management of COVID-19. Pharm Res  2020,3(1),26-29","journal-title":"Pharm Res"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1007\/s12011-020-02462-8","volume":"199","author":"Sharma P.","year":"2021","unstructured":"Sharma P.; Reddy P.K.; Kumar B.; Trace element zinc, a nature\u2019s gift to fight unprecedented global pandemic COVID-19. Biol Trace Elem Res  2021,199(9),3213-3221","journal-title":"Biol Trace Elem Res"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"46","DOI":"10.2174\/1876402914666220523105129","volume":"15","author":"Dewangan H.K.","year":"2023","unstructured":"Dewangan H.K.; Raghuvanshi A.; Shah K.; Emerging nanovaccine technology: Defense against infection by oral administration. Micro Nanosyst  2023,15(1),46-54","journal-title":"Micro Nanosyst"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3390\/antiox10050804","volume":"10","author":"Abulmeaty M.M.A.","year":"2021","unstructured":"Abulmeaty M.M.A.; Aljuraiban G.S.; Shaikh S.M.; ALEid N.E.; Mazrou L.R.A.; Turjoman A.A.; Aldosari M.S.; Razak S.; Sayed E.M.M.; Areabi T.M.; Alsalafi R.M.; Helio A.Y.S.; Almutairy A.B.; Molla H.N.; The efficacy of antioxidant oral supplements on the progression of COVID-19 in non-critically Ill patients: a randomized controlled trial. Antioxidants  2021,10(5),804","journal-title":"Antioxidants"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"570122","DOI":"10.3389\/fimmu.2020.570122","volume":"11","author":"Mrityunjaya M.","year":"2020","unstructured":"Mrityunjaya M.; Pavithra V.; Neelam R.; Janhavi P.; Halami P.M.; Ravindra P.V.; Immune-boosting, antioxidant and anti-inflammatory food supplements targeting pathogenesis of COVID-19. Front Immunol  2020,11,570122","journal-title":"Front Immunol"},{"key":"ref=40","first-page":"4529","volume":"24","author":"Joshi T.","year":"2020","unstructured":"Joshi T.; Joshi T.; Sharma P.; Mathpal S.; Pundir H.; Bhatt V.; Chandra S.; In silico screening of natural compounds against COVID-19 by targeting Mpro and ACE2 using molecular docking. Eur Rev Med Pharmacol Sci  2020,24(8),4529-4536","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"179","DOI":"10.26434\/chemrxiv.11935722.v1","volume":"45","author":"Shaghaghi N.","year":"2020","unstructured":"Shaghaghi N.; Molecular docking study of novel COVID-19 protease with low risk terpenoides compounds of plants. ChemRxiv  2020,45,179-199","journal-title":"ChemRxiv"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"469","DOI":"10.2174\/15734099MTA1lOTgfz","volume":"17","author":"Serseg T.","year":"2021","unstructured":"Serseg T.; Benarous K.; Yousfi M.; Hispidin and lepidine E: Two natural compounds and folic acid as potential inhibitors of 2019-novel coronavirus main protease (2019-nCoVMpro), molecular docking and SAR study. Curr Computeraided Drug Des  2021,17(3),469-479","journal-title":"Curr Computeraided Drug Des"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"19570","DOI":"10.1039\/D0RA03582C","volume":"10","author":"Owis A.I.","year":"2020","unstructured":"Owis A.I.; Hawary E.M.S.; Amir E.D.; Aly O.M.; Abdelmohsen U.R.; Kamel M.S.; Molecular docking reveals the potential of Salvadora persica flavonoids to inhibit COVID-19 virus main protease. RSC Advances  2020,10(33),19570-19575","journal-title":"RSC Advances"},{"key":"ref=44","first-page":"1","author":"Sharma A.D.","year":"2020","unstructured":"Sharma A.D.; Kaur I.; Molecular docking studies on Jensenone from eucalyptus essential oil as a potential inhibitor of COVID 19 corona virus infection. arXiv:200400217  2020,1-6","journal-title":"arXiv:200400217"},{"key":"ref=45","first-page":"1","volume":"24","author":"Mahmud S.","year":"2020","unstructured":"Mahmud S.; Uddin M.A.R.; Zaman M.; Sujon K.M.; Rahman M.E.; Shehab M.N.; Islam A.; Alom M.W.; Amin A.; Akash A.S.; Molecular docking and dynamics study of natural compound for potential inhibition of main protease of SARS-CoV-2. J Biomol Struct Dyn  2020,24,1-9","journal-title":"J Biomol Struct Dyn"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1111\/jcmm.17841","volume":"27","author":"Gao S.","year":"2023","unstructured":"Gao S.; Tan H.; Li D.; Oridonin suppresses gastric cancer SGC\u20107901 cell proliferation by targeting the TNF\u2010alpha\/androgen receptor\/ TGF\u2010beta signalling pathway axis. J Cell Mol Med  2023,27(18),2661-2674","journal-title":"J Cell Mol Med"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/22221751.2020.1719902","volume":"9","author":"Chan J.F.W.","year":"2020","unstructured":"Chan J.F.W.; Kok K.H.; Zhu Z.; Chu H.; To K.K.W.; Yuan S.; Yuen K.Y.; Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect  2020,9(1),221-236","journal-title":"Emerg Microbes Infect"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3390\/cells10040821","volume":"10","author":"Yadav R.","year":"2021","unstructured":"Yadav R.; Chaudhary J.K.; Jain N.; Chaudhary P.K.; Khanra S.; Dhamija P.; Sharma A.; Kumar A.; Handu S.; Role of structural and non-structural proteins and therapeutic targets of SARS-CoV-2 for COVID-19. Cells  2021,10(4),821","journal-title":"Cells"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"5365","DOI":"10.1007\/s11033-020-05621-1","volume":"47","author":"Mirzaei R.","year":"2020","unstructured":"Mirzaei R.; Karampoor S.; Sholeh M.; Moradi P.; Ranjbar R.; Ghasemi F.; A contemporary review on pathogenesis and immunity of COVID-19 infection. Mol Biol Rep  2020,47(7),5365-5376","journal-title":"Mol Biol Rep"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1002\/jmv.25981","volume":"92","author":"Lange C.","year":"2020","unstructured":"Lange C.; Wolf J.; Haedrich A.C.; Schlecht A.; Boneva S.; Lapp T.; Horres R.; Agostini H.; Martin G.; Reinhard T.; Schlunck G.; Expression of the COVID\u201019 receptor ACE2 in the human conjunctiva. J Med Virol  2020,92(10),2081-2086","journal-title":"J Med Virol"},{"key":"ref=51","doi-asserted-by":"publisher","DOI":"10.5530\/bems.7.2.7","volume":"7","author":"Kumar A.","year":"2021","unstructured":"Kumar A.; Molecular profiling of Neprilysin expression and its interactions with SARS-CoV-2 spike proteins to develop evidence base pharmacological approaches for therapeutic intervention. Res Square  2021,7(2)","journal-title":"Res Square"},{"key":"ref=52","first-page":"1","volume":"6","author":"Goothy S.S.K.","year":"2020","unstructured":"Goothy S.S.K.; Network proteins of angiotensin-converting enzyme 2 but not angiotensin-converting enzyme 2 itself are host cell receptors for SARS-Coronavirus-2 attachment. BEMS Reports, 2020. Bio Eng Med Sci Rep  2020,6(1),1-05","journal-title":"Bio Eng Med Sci Rep"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41368-020-0074-x","volume":"12","author":"Xu H.","year":"2020","unstructured":"Xu H.; Zhong L.; Deng J.; Peng J.; Dan H.; Zeng X.; Li T.; Chen Q.; High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci  2020,12(1),8","journal-title":"Int J Oral Sci"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12916-020-01673-z","volume":"18","author":"Hou Y.","year":"2020","unstructured":"Hou Y.; Zhao J.; Martin W.; Kallianpur A.; Chung M.K.; Jehi L.; Sharifi N.; Erzurum S.; Eng C.; Cheng F.; New insights into genetic susceptibility of COVID-19: An ACE2 and TMPRSS2 polymorphism analysis. BMC Med  2020,18(1),216","journal-title":"BMC Med"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jmii.2020.05.001","volume":"54","author":"Gao Z.","year":"2021","unstructured":"Gao Z.; Xu Y.; Sun C.; Wang X.; Guo Y.; Qiu S.; Ma K.; A systematic review of asymptomatic infections with COVID-19. J Microbiol Immunol Infect  2021,54(1),12-16","journal-title":"J Microbiol Immunol Infect"},{"key":"ref=56","first-page":"E304","volume":"61","author":"Alimohamadi Y.","year":"2020","unstructured":"Alimohamadi Y.; Sepandi M.; Taghdir M.; Hosamirudsari H.; Determine the most common clinical symptoms in COVID-19 patients: A systematic review and meta-analysis. J Prev Med Hyg  2020,61(3),E304-E312","journal-title":"J Prev Med Hyg"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"7234","DOI":"10.33263\/BRIAC106.72347242","volume":"10","author":"Hadi A.G.","year":"2020","unstructured":"Hadi A.G.; Kadhom M.; Hairunisa N.; Yousif E.; Mohammed S.A.; A review on COVID-19: Origin, spread, symptoms, treatment, and prevention. Bio Res Appl Chem  2020,10(6),7234-7242","journal-title":"Bio Res Appl Chem"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/jmv.26232","volume":"93","author":"Hu B.","year":"2021","unstructured":"Hu B.; Huang S.; Yin L.; The cytokine storm and COVID\u201019. J Med Virol  2021,93(1),250-256","journal-title":"J Med Virol"},{"key":"ref=59","first-page":"97","author":"Baqi H.R.","year":"2020","unstructured":"Baqi H.R.; Farag H.A.M.; Bilbeisi E.A.H.H.; Askandar R.H.; Afifi E.A.M.;  Oxidative stress and its association with COVID-19: A narrative review  2020,97-105","journal-title":"Oxidative stress and its association with COVID-19: A narrative review"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"605908","DOI":"10.3389\/fphys.2020.605908","volume":"11","author":"Chang R.","year":"2021","unstructured":"Chang R.; Mamun A.; Dominic A.; Le N.T.; SARS-CoV-2 mediated endothelial dysfunction: The potential role of chronic oxidative stress. Front Physiol  2021,11,605908","journal-title":"Front Physiol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ejim.2020.04.037","volume":"76","author":"Verdecchia P.","year":"2020","unstructured":"Verdecchia P.; Cavallini C.; Spanevello A.; Angeli F.; The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Eur J Intern Med  2020,76,14-20","journal-title":"Eur J Intern Med"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"598400","DOI":"10.3389\/fcvm.2020.598400","volume":"7","author":"Roberts K.A.","year":"2020","unstructured":"Roberts K.A.; Colley L.; Agbaedeng T.A.; Hughes E.G.M.; Ross M.D.; Vascular manifestations of COVID-19\u2013thromboembolism and microvascular dysfunction. Front Cardiovasc Med  2020,7,598400","journal-title":"Front Cardiovasc Med"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.2217\/fmb-2020-0110","volume":"15","author":"Kermani K.E.","year":"2020","unstructured":"Kermani K.E.; Khalili H.; Karimzadeh I.; Pathogenesis, clinical manifestations and complications of coronavirus disease 2019 (COVID-19). Future Microbiol  2020,15,1287-1305","journal-title":"Future Microbiol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.xphs.2018.07.013","volume":"108","author":"Deepika D.","year":"2019","unstructured":"Deepika D.; Dewangan H.K.; Maurya L.; Singh S.; Intranasal drug delivery of frovatriptan succinate loaded polymeric nanoparticles for brain targeting. J Pharm Sci  2019,108(2),851-859","journal-title":"J Pharm Sci"},{"key":"ref=65","first-page":"2033","volume":"46","author":"Dewangan H.K.","year":"2018","unstructured":"Dewangan H.K.; Pandey T.; Singh S.; Nanovaccine for immunotherapy and reduced hepatitis-B virus in humanized model. Artif Cells Nanomed Biotechnol  2018,46(8),2033-2042","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2020033273","volume":"37","author":"Garg A.","year":"2020","unstructured":"Garg A.; Dewangan H.K.; Nanoparticles as adjuvants in vaccine delivery. Crit Rev Ther Drug Carrier Syst  2020,37(2),183-204","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"6619","DOI":"10.1002\/jmv.27218","volume":"93","author":"Hattato\u011flu D.G.","year":"2021","unstructured":"Hattato\u011flu D.G.; Y\u0131ld\u0131z B.P.; Comparison of clinical and biochemical features of hospitalized COVID\u201019 and influenza pneumonia patients. J Med Virol  2021,93(12),6619-6627","journal-title":"J Med Virol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"26","DOI":"10.5493\/wjem.v12.i2.26","volume":"12","author":"Zhamankulov A.","year":"2022","unstructured":"Zhamankulov A.; Rozenson R.; Morenko M.; Akhmetova U.; Tyo A.; Poddighe D.; Comparison between SARS-CoV-2 positive and negative pneumonia in children: A retrospective analysis at the beginning of the pandemic. World J Exp Med  2022,12(2),26-35","journal-title":"World J Exp Med"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1002\/jmv.26460","volume":"93","author":"Pasomsub E.","year":"2021","unstructured":"Pasomsub E.; Watcharananan S.P.; Watthanachockchai T.; Rakmanee K.; Tassaneetrithep B.; Kiertiburanakul S.; Phuphuakrat A.; Saliva sample pooling for the detection of SARS\u2010CoV\u20102. J Med Virol  2021,93(3),1506-1511","journal-title":"J Med Virol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s13337-021-00692-5","volume":"32","author":"Munne K.","year":"2021","unstructured":"Munne K.; Bhanothu V.; Bhor V.; Patel V.; Mahale S.D.; Pande S.; Detection of SARS-CoV-2 infection by RT-PCR test: Factors influencing interpretation of results. Virusdisease  2021,32(2),187-189","journal-title":"Virusdisease"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.2174\/0113816128279248231210172053","volume":"29","author":"Rai A.","year":"2023","unstructured":"Rai A.; Shah K.; Dewangan H.K.; Review on the artificial intelligence-based nanorobotics targeted drug delivery system for brain-specific targeting. Curr Pharm Des  2023,29(44),3519-3531","journal-title":"Curr Pharm Des"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.clinbiochem.2021.12.011","volume":"117","author":"Tran N.K.","year":"2023","unstructured":"Tran N.K.; Albahra S.; Rashidi H.; May L.; Innovations in infectious disease testing: Leveraging COVID-19 pandemic technologies for the future. Clin Biochem  2023,117,10-15","journal-title":"Clin Biochem"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s12931-022-02190-8","volume":"23","author":"Bekbossynova M.","year":"2022","unstructured":"Bekbossynova M.; Akhmaltdinova L.; Dossybayeva K.; Tauekelova A.; Smagulova Z.; Tsechoeva T.; Turebayeva G.; Sailybayeva A.; Kalila Z.; Mirashirova T.; Muratov T.; Poddighe D.; Central and effector memory T cells in peripheral blood of patients with interstitial pneumonia: Preliminary clues from a COVID-19 study. Respir Res  2022,23(1),278","journal-title":"Respir Res"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.3390\/microorganisms11112737","volume":"11","author":"Saihati A.H.A.","year":"2023","unstructured":"Saihati A.H.A.; Hussein H.A.M.; Thabet A.A.; Wardany A.A.; Mahmoud S.Y.; Farrag E.S.; Mohamed T.I.A.; Fathy S.M.; Elnosary M.E.; Sobhy A.; Ahmed A.E.; Adly E.A.M.; Shenawy E.F.S.; Elsadek A.A.; Rayan A.; Zahran Z.A.M.; Badawy E.O.; Naggar E.M.G.M.; Afifi M.M.; Zahran A.M.; Memory T.; Memory T cells discrepancies in COVID-19 patients. Microorganisms  2023,11(11),2737","journal-title":"Microorganisms"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1038\/s12276-020-00486-7","volume":"52","author":"Lee H.G.","year":"2020","unstructured":"Lee H.G.; Cho M.J.; Choi J.M.; Bystander CD4 T cells: Crossroads between innate and adaptive immunity. Exp Mol Med  2020,52(8),1255-1263","journal-title":"Exp Mol Med"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2174\/1389450124666221205162256","volume":"24","author":"Dewangan H.K.","year":"2023","unstructured":"Dewangan H.K.; Raghuvanshi A.; Shah K.; Review: Emerging trends and future challenges of nanovaccine delivery via nasal route. Curr Drug Targets  2023,24(3),261-273","journal-title":"Curr Drug Targets"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.smim.2009.02.004","volume":"21","author":"Stemberger C.","year":"2009","unstructured":"Stemberger C.; Neuenhahn M.; Gebhardt F.E.; Schiemann M.; Buchholz V.R.; Busch D.H.; Stem cell-like plasticity of na\u00efve and distinct memory CD8+ T cell subsets. Semin Immunol  2009,21(2),62-68","journal-title":"Semin Immunol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/s41590-020-0782-6","volume":"21","author":"Peng Y.","year":"2020","unstructured":"Peng Y.; Mentzer A.J.; Liu G.; Yao X.; Yin Z.; Dong D.; Dejnirattisai W.; Rostron T.; Supasa P.; Liu C.; Camacho L.C.; Campos S.J.; Zhao Y.; Stuart D.I.; Paesen G.C.; Grimes J.M.; Antson A.A.; Bayfield O.W.; Hawkins D.E.D.P.; Ker D.S.; Wang B.; Turtle L.; Subramaniam K.; Thomson P.; Zhang P.; Dold C.; Ratcliff J.; Simmonds P.; Silva d.T.; Sopp P.; Wellington D.; Rajapaksa U.; Chen Y.L.; Salio M.; Napolitani G.; Paes W.; Borrow P.; Kessler B.M.; Fry J.W.; Schwabe N.F.; Semple M.G.; Baillie J.K.; Moore S.C.; Openshaw P.J.M.; Ansari M.A.; Dunachie S.; Barnes E.; Frater J.; Kerr G.; Goulder P.; Lockett T.; Levin R.; Zhang Y.; Jing R.; Ho L.P.; Barnes E.; Dong D.; Dong T.; Dunachie S.; Frater J.; Goulder P.; Kerr G.; Klenerman P.; Liu G.; McMichael A.; Napolitani G.; Ogg G.; Peng Y.; Salio M.; Yao X.; Yin Z.; Baillie K.J.; Klenerman P.; Mentzer A.J.; Moore S.C.; Openshaw P.J.M.; Semple M.G.; Stuart D.I.; Turtle L.; Cornall R.J.; Conlon C.P.; Klenerman P.; Screaton G.R.; Mongkolsapaya J.; McMichael A.; Knight J.C.; Ogg G.; Dong T.; Broad and strong memory CD4 and CD8 T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19. Nat Immunol  2020,21(11),1336-1345","journal-title":"Nat Immunol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1002\/jmv.25965","volume":"92","author":"Liu J.","year":"2020","unstructured":"Liu J.; Liu S.; The management of coronavirus disease 2019 (COVID\u201019). J Med Virol  2020,92(9),1484-1490","journal-title":"J Med Virol"},{"key":"ref=80","first-page":"22","year":"2020","unstructured":"US Food and Drug Administration FDA approves first treatment for COVID-19. Food and Drug Administration news release. Published  2020(October),22","journal-title":"Published"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"850","DOI":"10.3390\/pathogens9100850","volume":"9","author":"Jain S.","year":"2020","unstructured":"Jain S.; Khaiboullina S.F.; Baranwal M.; Immunological perspective for ebola virus infection and various treatment measures taken to fight the disease. Pathogens  2020,9(10),850","journal-title":"Pathogens"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.bbrc.2020.11.043","volume":"538","author":"Santoro M.G.","year":"2021","unstructured":"Santoro M.G.; Carafoli E.; Remdesivir: From ebola to COVID-19. Biochem Biophys Res Commun  2021,538,145-150","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3390\/ph14070655","volume":"14","author":"Deb S.","year":"2021","unstructured":"Deb S.; Reeves A.A.; Hopefl R.; Bejusca R.; ADME and pharmacokinetic properties of remdesivir: Its drug interaction potential. Pharmaceuticals  2021,14(7),655","journal-title":"Pharmaceuticals"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"6385","DOI":"10.1038\/s41467-020-19761-2","volume":"11","author":"Buckland M.S.","year":"2020","unstructured":"Buckland M.S.; Galloway J.B.; Fhogartaigh C.N.; Meredith L.; Provine N.M.; Bloor S.; Ogbe A.; Zelek W.M.; Smielewska A.; Yakovleva A.; Mann T.; Bergamaschi L.; Turner L.; Mescia F.; Toonen E.J.M.; Hackstein C.P.; Akther H.D.; Vieira V.A.; Gutierrez C.L.; Periselneris J.; Alikhan K.S.; Grigoriadou S.; Vaghela D.; Lear S.E.; T\u00f6r\u00f6k M.E.; Hamilton W.L.; Stockton J.; Quick J.; Nelson P.; Hunter M.; Coulter T.I.; Devlin L.; Bradley J.R.; Smith K.G.C.; Ouwehand W.H.; Estcourt L.; Harvala H.; Roberts D.J.; Wilkinson I.B.; Screaton N.; Loman N.; Doffinger R.; Lyons P.A.; Morgan B.P.; Goodfellow I.G.; Klenerman P.; Lehner P.J.; Matheson N.J.; Thaventhiran J.E.D.; Treatment of COVID-19 with remdesivir in the absence of humoral immunity: A case report. Nat Commun  2020,11(1),6385","journal-title":"Nat Commun"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/01.NAJ.0000688196.83625.b1","volume":"120","author":"Aschenbrenner DS","year":"2020","unstructured":"Aschenbrenner DS; Remdesivir Receives emergency use authorization for severely ill patients with COVID-19. AJN Amer j Nur  2020,120(7),26","journal-title":"AJN Amer j Nur"},{"key":"ref=86","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.21873\/invivo.12134","volume":"34","author":"Lehrer S","year":"2020","unstructured":"Lehrer S; Rheinstein PH; Ivermectin docks to the SARS-CoV-2 spike receptor-binding domain attached to ACE2. In Vivo  2020,34(5),3023-3026","journal-title":"In Vivo"},{"key":"ref=87","first-page":"1","author":"Zaidi A.K.","year":"2021","unstructured":"Zaidi A.K.; Mobaraki D.P.; The mechanisms of action of Ivermectin against SARS-CoV-2: An evidence-based clinical review article. J Antibiot  2021,1-13","journal-title":"J Antibiot"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"104805","DOI":"10.1016\/j.antiviral.2020.104805","volume":"178","author":"Bray M.","year":"2020","unstructured":"Bray M.; Rayner C.; No\u00ebl F.; Jans D.; Wagstaff K.; Ivermectin and COVID-19: A report in antiviral research, widespread interest, an FDA warning, two letters to the editor and the authors\u2019 responses. Antiviral Res  2020,178,104805-104805","journal-title":"Antiviral Res"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s00203-021-02606-x","volume":"204","author":"Hebbani A.V.","year":"2022","unstructured":"Hebbani A.V.; Pulakuntla S.; Pannuru P.; Aramgam S.; Badri K.R.; Reddy V.D.; COVID-19: Comprehensive review on mutations and current vaccines. Arch Microbiol  2022,204(1),8","journal-title":"Arch Microbiol"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"112791","DOI":"10.1016\/j.jim.2020.112791","volume":"481-482","author":"Dewangan H.K.","year":"2020","unstructured":"Dewangan H.K.; Rational application of nanoadjuvant for mucosal vaccine delivery system. J Immunol Methods  2020,481-482,112791","journal-title":"J Immunol Methods"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"20","DOI":"10.2174\/0115734137283662240129073747","volume":"20","author":"Dubey R.K.","year":"2024","unstructured":"Dubey R.K.; Shukla S.; Shah K.; Dewangan H.K.; A comprehensive review of self-assembly techniques used to fabricate as DNA origami, block copolymers, and colloidal nanostructures. Curr Nanosci  2024,20,20","journal-title":"Curr Nanosci"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3390\/biomed3020025","volume":"3","author":"Moura A.","year":"2023","unstructured":"Moura A.; Lopes L.; Matos L.C.; Machado J.; Criado M.B.; Converging paths: A comprehensive review of the synergistic approach between complementary medicines and western medicine in addressing COVID-19 in 2020. BioMed  2023,3(2),282-308","journal-title":"BioMed"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10787-015-0239-y","volume":"23","author":"Rainsford K.D.","year":"2015","unstructured":"Rainsford K.D.; Parke A.L.; Rashotte C.M.; Kean W.F.; Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases. Inflammopharmacology  2015,23(5),231-269","journal-title":"Inflammopharmacology"},{"key":"ref=94","first-page":"1","year":"2020","unstructured":"Recommendation for empiric use of hydroxychloroquine for prophylaxis of SARS-CoV-2 infection. Indian Counc Med Res  2020,1-1","journal-title":"Indian Counc Med Res"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"181","DOI":"10.4155\/tde-2023-0109","volume":"15","author":"Rajni S.K.","year":"2024","unstructured":"Rajni S.K.; Shah K.; Dewangan H.K.; Delivery of nano-emulgel carrier: Optimization, evaluation and in vivo anti-inflammation estimations for osteoarthritis. Ther Deliv  2024,15(3),181-192","journal-title":"Ther Deliv"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1136\/postgradmedj-2020-137785","volume":"96","author":"Sinha N.","year":"2020","unstructured":"Sinha N.; Balayla G.; Hydroxychloroquine and COVID-19. Postgrad Med J  2020,96(1139),550-555","journal-title":"Postgrad Med J"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s12272-020-01258-7","volume":"43","author":"Zou L.","year":"2020","unstructured":"Zou L.; Dai L.; Zhang X.; Zhang Z.; Zhang Z.; Hydroxychloroquine and chloroquine: A potential and controversial treatment for COVID-19. Arch Pharm Res  2020,43(8),765-772","journal-title":"Arch Pharm Res"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"101337","DOI":"10.1016\/j.jddst.2019.101337","volume":"54","author":"Sharma V.","year":"2019","unstructured":"Sharma V.; Dewangan H.K.; Maurya L.; Vats K.; Verma H.; Singh S.; Rational design and in-vivo estimation of ivabradine hydrochloride loaded nanoparticles for management of stable angina. J Drug Deliv Sci Technol  2019,54,101337-101346","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"105177","DOI":"10.1016\/j.arabjc.2023.105177","volume":"16","author":"Dubey K.R.","year":"2023","unstructured":"Dubey K.R.; Shah K.; Obaidullah A.J.; Alanazi M.M.; Alotaibi F.H.; Dewangan K.H.; Nanostructured lipid carriers of ivabradine hydrochloride: Optimization, characterization and in-vivo estimation for management of stable angina. Arab J Chem  2023,16(10),105177","journal-title":"Arab J Chem"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1001\/jama.2020.16253","volume":"324","author":"Thomson K.","year":"2020","unstructured":"Thomson K.; Nachlis H.; Emergency use authorizations during the COVID-19 pandemic: Lessons from hydroxychloroquine for vaccine authorization and approval. JAMA  2020,324(13),1282-1283","journal-title":"JAMA"},{"key":"ref=101","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.2147\/TCRM.S3285","volume":"4","author":"Chandwani A.","year":"2008","unstructured":"Chandwani A.; Shuter J.; Lopinavir\/ritonavir in the treatment of HIV-1 infection: A review. Ther Clin Risk Manag  2008,4(5),1023-1033","journal-title":"Ther Clin Risk Manag"},{"key":"ref=102","first-page":"e68","volume":"382","author":"Dalerba P.","year":"2020","unstructured":"Dalerba P.; Levin B.; Thompson J.L.; A Trial of Lopinavir-Ritonavir in COVID-19. N Engl J Med  2020,382(21),e68","journal-title":"N Engl J Med"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","volume":"382","author":"Cao B.","year":"2020","unstructured":"Cao B.; Wang Y.; Wen D.; Liu W.; Wang J.; Fan G.; Ruan L.; Song B.; Cai Y.; Wei M.; Li X.; Xia J.; Chen N.; Xiang J.; Yu T.; Bai T.; Xie X.; Zhang L.; Li C.; Yuan Y.; Chen H.; Li H.; Huang H.; Tu S.; Gong F.; Liu Y.; Wei Y.; Dong C.; Zhou F.; Gu X.; Xu J.; Liu Z.; Zhang Y.; Li H.; Shang L.; Wang K.; Li K.; Zhou X.; Dong X.; Qu Z.; Lu S.; Hu X.; Ruan S.; Luo S.; Wu J.; Peng L.; Cheng F.; Pan L.; Zou J.; Jia C.; Wang J.; Liu X.; Wang S.; Wu X.; Ge Q.; He J.; Zhan H.; Qiu F.; Guo L.; Huang C.; Jaki T.; Hayden F.G.; Horby P.W.; Zhang D.; Wang C.; A trial of lopinavir ritonavir in adults hospitalized with severe COVID-19. N Engl J Med  2020,382(19),1787-1799","journal-title":"N Engl J Med"},{"key":"ref=104","first-page":"3390","volume":"24","author":"Ye X.T.","year":"2020","unstructured":"Ye X.T.; Luo Y.L.; Xia S.C.; Sun Q.F.; Ding J.G.; Zhou Y.; Chen W.; Wang X.F.; Zhang W.W.; Du W.J.; Ruan Z.W.; Hong L.; Clinical efficacy of lopinavir\/ritonavir in the treatment of Coronavirus disease 2019. Eur Rev Med Pharmacol Sci  2020,24(6),3390-3396","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"e7966","DOI":"10.5867\/medwave.2020.06.7966","volume":"20","author":"Paiva V.F.","year":"2020","unstructured":"Paiva V.F.; Izcovich A.; Ragusa M.; Rada G.; Lopinavir\/ritonavir for COVID-19: A living systematic review. Medwave  2020,20(6),e7966","journal-title":"Medwave"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.3390\/jcm9072050","volume":"9","author":"Meini S.","year":"2020","unstructured":"Meini S.; Pagotto A.; Longo B.; Vendramin I.; Pecori D.; Tascini C.; Role of Lopinavir\/Ritonavir in the treatment of COVID-19: A review of current evidence, guideline recommendations, and perspectives. J Clin Med  2020,9(7),2050","journal-title":"J Clin Med"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.antiviral.2014.04.006","volume":"107","author":"Blaising J.","year":"2014","unstructured":"Blaising J.; Polyak S.J.; P\u00e9cheur E.I.; Arbidol as a broad-spectrum antiviral: An update. Antiviral Res  2014,107,84-94","journal-title":"Antiviral Res"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/j.jinf.2020.03.060","volume":"81","author":"Zhu Z.","year":"2020","unstructured":"Zhu Z.; Lu Z.; Xu T.; Chen C.; Yang G.; Zha T.; Lu J.; Xue Y.; Arbidol monotherapy is superior to lopinavir\/ritonavir in treating COVID-19. J Infect  2020,81(1),e21-e23","journal-title":"J Infect"},{"key":"ref=109","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.medj.2020.04.001","volume":"1","author":"Li Y","year":"2020","unstructured":"Li Y; Xie Z; Lin W; Cai W; Wen C; Guan Y; Mo X; Wang J; Wang Y; Peng P; Efficacy and safety of lopinavir\/ritonavir or arbidol in adult patients with mild\/moderate COVID-19: An exploratory randomized controlled trial. Med  2020,1,105-113","journal-title":"Med"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jinf.2020.03.002","volume":"81","author":"Deng L.","year":"2020","unstructured":"Deng L.; Li C.; Zeng Q.; Liu X.; Li X.; Zhang H.; Hong Z.; Xia J.; Arbidol combined with LPV\/r versus LPV\/r alone against Corona Virus Disease 2019: A retrospective cohort study. J Infect  2020,81(1),e1-e5","journal-title":"J Infect"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2174\/1872210516666220819104853","volume":"17","author":"Dewangan H.K.","year":"2023","unstructured":"Dewangan H.K.; Rai A.; Shah K.; Sharma R.; A comprehensive review on COVID-19: Emphasis on current vaccination and nanotechnology aspects. Recent Pat Nanotechnol  2023,17(4),359-377","journal-title":"Recent Pat Nanotechnol"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/jmv.26256","volume":"93","author":"Huang D.","year":"2021","unstructured":"Huang D.; Yu H.; Wang T.; Yang H.; Yao R.; Liang Z.; Efficacy and safety of umifenovir for coronavirus disease 2019 (COVID\u201019): A systematic review and meta\u2010analysis. J Med Virol  2021,93(1),481-490","journal-title":"J Med Virol"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2183\/pjab.93.027","volume":"93","author":"Furuta Y.","year":"2017","unstructured":"Furuta Y.; Komeno T.; Nakamura T.; Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase. Proc Jpn Acad, Ser B, Phys Biol Sci  2017,93(7),449-463","journal-title":"Proc Jpn Acad, Ser B, Phys Biol Sci"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1186\/s13054-020-03137-5","volume":"24","author":"Yamamura H.","year":"2020","unstructured":"Yamamura H.; Matsuura H.; Nakagawa J.; Fukuoka H.; Domi H.; Chujoh S.; Effect of favipiravir and an anti-inflammatory strategy for COVID-19. Crit Care  2020,24(1),413","journal-title":"Crit Care"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1101\/2020.06.24.20133249","volume":"11","author":"Rattanaumpawan P.","year":"2020","unstructured":"Rattanaumpawan P.; Jirajariyavej S.; Lerdlamyong K.; Palavutitotai N.; Saiyarin J.; Real-world experience with favipiravir for treatment of COVID-19 in Thailand: Results from a multi-center observational study. Antibiotics  2020,11(6),805","journal-title":"Antibiotics"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"14884","DOI":"10.1038\/s41598-023-42195-x","volume":"13","year":"2023","unstructured":"Siripongboonsitti, T, Muadchimkaew, M, Tawinprai, K, et al. Favipiravir treatment in non-severe COVID-19: Promising results from multicenter propensity score-matched study (FAVICOV). Sci Rep 2023,13(1),14884"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S2055-6640(20)30016-9","volume":"6","author":"Pilkington V.","year":"2020","unstructured":"Pilkington V.; Pepperrell T.; Hill A.; A review of the safety of favipiravir \u2013 a potential treatment in the COVID-19 pandemic? J Virus Erad  2020,6(2),45-51","journal-title":"J Virus Erad"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2165\/00003495-200161020-00011","volume":"61","author":"McClellan K.","year":"2001","unstructured":"McClellan K.; Perry C.M.; Oseltamivir. Drugs  2001,61(2),263-283","journal-title":"Drugs"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"e202301468","DOI":"10.1002\/cbdv.202301468","volume":"21","author":"Sharma A.N.","year":"2024","unstructured":"Sharma A.N.; Dewangan H.K.; Upadhyay P.K.; Comprehensive review on herbal medicine: Emphasis on current therapy and role of phytoconstituents for cancer treatment. Chem Biodivers  2024,21(3),e202301468","journal-title":"Chem Biodivers"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1002\/ptr.6893","volume":"35","author":"Adhikari B.","year":"2021","unstructured":"Adhikari B.; Marasini B.P.; Rayamajhee B.; Bhattarai B.R.; Lamichhane G.; Khadayat K.; Adhikari A.; Khanal S.; Parajuli N.; Potential roles of medicinal plants for the treatment of viral diseases focusing on COVID\u201019: A review. Phytother Res  2021,35(3),1298-1312","journal-title":"Phytother Res"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"101214","DOI":"10.1016\/j.ctcp.2020.101214","volume":"40","author":"Mirzaie A.","year":"2020","unstructured":"Mirzaie A.; Halaji M.; Dehkordi F.S.; Ranjbar R.; Noorbazargan H.; A narrative literature review on traditional medicine options for treatment of corona virus disease 2019 (COVID-19). Complement Ther Clin Pract  2020,40,101214","journal-title":"Complement Ther Clin Pract"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s43450-023-00367-w","volume":"33","author":"Pe\u00f1aloza E.M.C.","year":"2023","unstructured":"Pe\u00f1aloza E.M.C.; Costa S.S.; Calderon H.O.; Medicinal plants in peru as a source of immunomodulatory drugs potentially useful against COVID-19. Rev Bras Farmacogn  2023,33(2),237-258","journal-title":"Rev Bras Farmacogn"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jnutbio.2019.03.009","volume":"69","author":"Zhang L.","year":"2019","unstructured":"Zhang L.; Virgous C.; Si H.; Synergistic anti-inflammatory effects and mechanisms of combined phytochemicals. J Nutr Biochem  2019,69,19-30","journal-title":"J Nutr Biochem"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s43450-022-00254-w","volume":"32","author":"Devi A.","year":"2022","unstructured":"Devi A.; Dwibedi V.; Rath S.K.; Khan Z.A.; Theories and mechanism of aging and longevity through evolutionary lens: A coalition of plant anti-oxidants. Rev Bras Farmacogn  2022,32(3),291-320","journal-title":"Rev Bras Farmacogn"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/14756366.2019.1690480","volume":"35","author":"Jo S.","year":"2020","unstructured":"Jo S.; Kim S.; Shin D.H.; Kim M.S.; Inhibition of SARS-CoV 3CL protease by flavonoids. J Enzyme Inhib Med Chem  2020,35(1),145-151","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.3390\/molecules28062470","volume":"28","author":"Giordano D.","year":"2023","unstructured":"Giordano D.; Facchiano A.; Carbone V.; Food plant secondary metabolites antiviral activity and their possible roles in SARS-CoV-2 treatment: An overview. Molecules  2023,28(6),2470","journal-title":"Molecules"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.tifs.2021.05.023","volume":"114","author":"Zhang Z.","year":"2021","unstructured":"Zhang Z.; Zhang X.; Bi K.; He Y.; Yan W.; Yang C.S.; Zhang J.; Potential protective mechanisms of green tea polyphenol EGCG against COVID-19. Trends Food Sci Technol  2021,114,11-24","journal-title":"Trends Food Sci Technol"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"1005466","DOI":"10.3389\/fnut.2022.1005466","volume":"9","author":"Baranova A.","year":"2023","unstructured":"Baranova A.; Song Y.; Cao H.; Yue W.; Zhang F.; Causal associations of tea intake with COVID-19 infection and severity. Front Nutr  2023,9,1005466","journal-title":"Front Nutr"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s11101-020-09720-6","volume":"20","author":"Solnier J.","year":"2021","unstructured":"Solnier J.; Fladerer J.P.; Flavonoids: A complementary approach to conventional therapy of COVID-19? Phytochem Rev  2021,20(4),773-795","journal-title":"Phytochem Rev"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"16","DOI":"10.26452\/ijrps.v11iSPL1.1976","volume":"11","author":"Goothy S","year":"2020","unstructured":"Goothy S; Choudhary A; Chakraborty H.; Potey G.; Chakraborty H.; Kumar A.H.; Mahadik V.; Ayurveda\u2019s holistic lifestyle approach for the management of Coronavirus disease (COVID-19): Possible role of tulsi. Inter J Res Pharm Sci  2020,11(SPL1),16-18","journal-title":"Inter J Res Pharm Sci"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"589044","DOI":"10.3389\/fphar.2020.589044","volume":"11","author":"Remali J.","year":"2021","unstructured":"Remali J.; Aizat W.M.; A review on plant bioactive compounds and their modes of action against coronavirus infection. Front Pharmacol  2021,11,589044","journal-title":"Front Pharmacol"},{"key":"ref=132","doi-asserted-by":"crossref","first-page":"122","DOI":"10.26452\/ijrps.v11iSPL1.2256","volume":"11","author":"Roy S","year":"2020","unstructured":"Roy S; Bhattacharyya P; Possible role of traditional medicinal plant Neem (Azadirachta indica) for the management of COVID-19 infection. Int J Res Pharm Sci  2020,11(SPL 1),122-125","journal-title":"Int J Res Pharm Sci"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","volume":"582","author":"Jin Z.","year":"2020","unstructured":"Jin Z.; Du X.; Xu Y.; Deng Y.; Liu M.; Zhao Y.; Zhang B.; Li X.; Zhang L.; Peng C.; Duan Y.; Yu J.; Wang L.; Yang K.; Liu F.; Jiang R.; Yang X.; You T.; Liu X.; Yang X.; Bai F.; Liu H.; Liu X.; Guddat L.W.; Xu W.; Xiao G.; Qin C.; Shi Z.; Jiang H.; Rao Z.; Yang H.; Structure of M from SARS-CoV-2 and discovery of its inhibitors. Nature  2020,582(7811),289-293","journal-title":"Nature"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"4282","DOI":"10.1038\/s41467-020-18096-2","volume":"11","author":"Vuong W.","year":"2020","unstructured":"Vuong W.; Khan M.B.; Fischer C.; Arutyunova E.; Lamer T.; Shields J.; Saffran H.A.; McKay R.T.; Belkum V.M.J.; Joyce M.A.; Young H.S.; Tyrrell D.L.; Vederas J.C.; Lemieux M.J.; Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication. Nat Commun  2020,11(1),4282","journal-title":"Nat Commun"},{"key":"ref=135","doi-asserted-by":"crossref","first-page":"101658","DOI":"10.1016\/j.jbc.2022.101658","volume":"298","author":"Chen Y.","year":"2020","unstructured":"Chen Y.; Yang W-H.; Huang L-M.; Wang Y-C.; Yang C-S.; Liu Y-L.; Hou M-H.; Tsai C-L.; Chou Y-Z.; Huang B-Y.; Hung C-F.; Hung Y-L.; Chen J-S.; Chiang Y-P.; Cho D-Y.; Jeng L-B.; Tsai C-H.; Hung M-C.; Inhibition of severe acute respiratory syndrome coronavirus 2 main protease by tafenoquine in vitro. J Biol Chem  2020,298(3),101658","journal-title":"J Biol Chem"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"5668","DOI":"10.1080\/07391102.2020.1790425","volume":"39","author":"Tripathi M.K.","year":"2021","unstructured":"Tripathi M.K.; Singh P.; Sharma S.; Singh T.P.; Ethayathulla A.S.; Kaur P.; Identification of bioactive molecule from Withania somnifera (Ashwagandha) as SARS-CoV-2 main protease inhibitor. J Biomol Struct Dyn  2021,39(15),5668-5681","journal-title":"J Biomol Struct Dyn"},{"key":"ref=137","volume":"11","author":"Kalra S.","year":"2023","unstructured":"Kalra S.; Chauhan A.; Identification of potent COVID-19 main protease (MPRO) inhibitors from flavonoids: In silico approach: Identification of potent COVID-19 main protease (MPRO) inhibitors from flavonoids. J Ayurveda Holist Med  2023,11(2)","journal-title":"J Ayurveda Holist Med"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"40507","DOI":"10.1007\/s11356-021-14195-9","volume":"28","author":"Shaldam M.A.","year":"2021","unstructured":"Shaldam M.A.; Yahya G.; Mohamed N.H.; Daim A.M.M.; Naggar A.Y.; In silico screening of potent bioactive compounds from honeybee products against COVID-19 target enzymes. Environ Sci Pollut Res Int  2021,28(30),40507-40514","journal-title":"Environ Sci Pollut Res Int"},{"key":"ref=139","first-page":"161","volume":"6","author":"Gill M.K.","year":"2019","unstructured":"Gill M.K.; Kumar S.; Sharma M.; Singh T.P.; Kumar K.; Kaur R.; Role of ashwagandha incorporated functional foods for betterment of human health: A review. J Agric Eng Food Technol  2019,6(2),161-165","journal-title":"J Agric Eng Food Technol"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/B978-0-12-802147-7.00052-8","author":"Bharti V.K.","year":"2016","unstructured":"Bharti V.K.; Malik J.K.; Gupta R.C.;  Ashwagandha: Multiple health benefits  2016,717-733","journal-title":"Ashwagandha: Multiple health benefits"},{"key":"ref=141","volume":"85","author":"Devi A.","year":"2023","unstructured":"Devi A.; Jain S.; Singhal D.; Ghosh A.; Kumar V.; Dwibedi V.; George N.; Khan Z.A.; Multiple ligand simultaneous docking analysis of epigallocatechin-o-gallate (green tea) and withaferin a (ashwagandha) effects on skin-aging related enzymes. Indian J Pharm Sci  2023,85(4)","journal-title":"Indian J Pharm Sci"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"105446","DOI":"10.1016\/j.jddst.2024.105446","volume":"93","author":"Mishra A.K.","year":"2024","unstructured":"Mishra A.K.; Rani L.; Singh R.; Dewangan H.K.; Sahoo P.K.; Kumar V.; Nanoinformatics and nanotechnology in anti-inflammatory therapy: A review. J Drug Deliv Sci Technol  2024,93,105446","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jaim.2019.10.004","volume":"11","author":"Gurav N.S.","year":"2020","unstructured":"Gurav N.S.; Gurav S.S.; Sakharwade S.N.; Studies on Ashwagandha Ghrita with reference to murcchana process and storage conditions. J Ayurveda Integr Med  2020,11(3),243-249","journal-title":"J Ayurveda Integr Med"},{"key":"ref=144","first-page":"227","volume":"8","author":"Jain R.","year":"2020","unstructured":"Jain R.; Mathur K.; An insight to curative effects of Ashwagandha (Withania somnifera), an Ayurveda herb. Faslnamah-i Giyahan-i Daruyi  2020,8,227-235","journal-title":"Faslnamah-i Giyahan-i Daruyi"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1201\/9781003242604-4","author":"Gayen K.C.","year":"2021","unstructured":"Gayen K.C.; Jana P.; Giri A.;  Use of Ashwagandha to Boost Immunity to Combat COVID-19  2021,47-52","journal-title":"Use of Ashwagandha to Boost Immunity to Combat COVID-19"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/s12291-020-00918-1","volume":"35","author":"Charan J.","year":"2020","unstructured":"Charan J.; Kaur R.; Bhardwaj P.; Kanchan T.; Mitra P.; Yadav D.; Sharma P.; Misra S.; Snapshot of COVID-19 related clinical trials in India. Indian J Clin Biochem  2020,35(4),418-422","journal-title":"Indian J Clin Biochem"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ijbiomac.2021.06.015","volume":"184","author":"Dhanjal J.K.","year":"2021","unstructured":"Dhanjal J.K.; Kumar V.; Garg S.; Subramani C.; Agarwal S.; Wang J.; Zhang H.; Kaul A.; Kalra R.S.; Kaul S.C.; Vrati S.; Sundar D.; Wadhwa R.; Molecular mechanism of anti-SARS-CoV2 activity of ashwagandha-derived withanolides. Int J Biol Macromol  2021,184,297-312","journal-title":"Int J Biol Macromol"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"22687","DOI":"10.21203\/rs.3.rs-22687\/v1","volume":"1","author":"Pandit M","year":"2020","unstructured":"Pandit M; Latha N; In silico studies reveal potential antiviral activity of phytochemicals from medicinal plants for the treatment of COVID-19 infection. Res Squa  2020,1,22687","journal-title":"Res Squa"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1080\/07391102.2020.1810778","volume":"40","author":"Shree P.","year":"2022","unstructured":"Shree P.; Mishra P.; Selvaraj C.; Singh S.K.; Chaube R.; Garg N.; Tripathi Y.B.; Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants \u2013 Withania somnifera (Ashwagandha), Tinospora cordifolia (Giloy) and Ocimum sanctum (Tulsi) \u2013 a molecular docking study. J Biomol Struct Dyn  2022,40(1),190-203","journal-title":"J Biomol Struct Dyn"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1201\/9781420006322","author":"Ravindran P.","year":"2007","unstructured":"Ravindran P.; Babu K.N.; Sivaraman K.; Turmeric: The genus Curcuma. In: Environment and Agriculture, Food Science and Technology, Physical Sciences  2007,504","journal-title":"In: Environment and Agriculture, Food Science and Technology, Physical Sciences"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"16","DOI":"10.4103\/ijdvl.IJDVL_1143_16","volume":"84","author":"Gopinath H.","year":"2018","unstructured":"Gopinath H.; Karthikeyan K.; Turmeric: A condiment, cosmetic and cure. Indian J Dermatol Venereol Leprol  2018,84(1),16-21","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"108729","DOI":"10.1016\/j.cbi.2019.108729","volume":"310","author":"Hay E.","year":"2019","unstructured":"Hay E.; Lucariello A.; Contieri M.; Esposito T.; Luca D.A.; Guerra G.; Perna A.; Therapeutic effects of turmeric in several diseases: An overview. Chem Biol Interact  2019,310,108729","journal-title":"Chem Biol Interact"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1039\/C5FO00485C","volume":"6","author":"Prasad S.","year":"2015","unstructured":"Prasad S.; Tyagi A.K.; Curcumin and its analogues: A potential natural compound against HIV infection and AIDS. Food Funct  2015,6(11),3412-3419","journal-title":"Food Funct"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.apsb.2014.06.006","volume":"4","author":"Qin Y.","year":"2014","unstructured":"Qin Y.; Lin L.; Chen Y.; Wu S.; Si X.; Wu H.; Zhai X.; Wang Y.; Tong L.; Pan B.; Zhong X.; Wang T.; Zhao W.; Zhong Z.; Curcumin inhibits the replication of enterovirus 71 in vitro. Acta Pharm Sin B  2014,4(4),284-294","journal-title":"Acta Pharm Sin B"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.foodchem.2009.09.011","volume":"119","author":"Chen D.Y.","year":"2010","unstructured":"Chen D.Y.; Shien J.H.; Tiley L.; Chiou S.S.; Wang S.Y.; Chang T.J.; Lee Y.J.; Chan K.W.; Hsu W.L.; Curcumin inhibits influenza virus infection and haemagglutination activity. Food Chem  2010,119(4),1346-1351","journal-title":"Food Chem"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1136\/gutjnl-2012-304299","volume":"63","author":"Anggakusuma","year":"2014","unstructured":"Anggakusuma ; Colpitts C.C.; Schang L.M.; Rachmawati H.; Frentzen A.; Pfaender S.; Behrendt P.; Brown R.J.P.; Bankwitz D.; Steinmann J.; Ott M.; Meuleman P.; Rice C.M.; Ploss A.; Pietschmann T.; Steinmann E.; Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells. Gut  2014,63(7),1137-1149","journal-title":"Gut"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"118001","DOI":"10.1016\/j.jep.2024.118001","volume":"329","author":"Gao S.","year":"2024","unstructured":"Gao S.; Tan H.; Gang J.; Inhibition of hepatocellular carcinoma cell proliferation through regulation of the Cell Cycle, AGE-RAGE, and Leptin signaling pathways by a compound formulation comprised of andrographolide, wogonin, and oroxylin A derived from Andrographis Paniculata(Burm.f.) Nees. J Ethnopharmacol  2024,329,118001","journal-title":"J Ethnopharmacol"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.2174\/1567201815666180716112457","volume":"15","author":"Lakshmi","year":"2018","unstructured":"Lakshmi ; Singh S.; Vijayakumar M.R.; Dewangan H.K.; Lipid-based aqueous core nanocapsules (ACNs) for encapsulating hydrophilic vinorelbine bitartrate: Preparation, optimization, characterization and in vitro safety assessment for intravenous administration. Curr Drug Deliv  2018,15(9),1284-1293","journal-title":"Curr Drug Deliv"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-0-387-46401-5_3","volume":"595","author":"Menon VP","year":"2007","unstructured":"Menon VP; Sudheer AR; Antioxidant and anti-inflammatory properties of curcumin. Adv Exp Med Biol  2007,595,105-125","journal-title":"Adv Exp Med Biol"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cbi.2008.05.003","volume":"174","author":"Ak T.","year":"2008","unstructured":"Ak T.; G\u00fcl\u00e7in \u0130.; Antioxidant and radical scavenging properties of curcumin. Chem Biol Interact  2008,174(1),27-37","journal-title":"Chem Biol Interact"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.redox.2013.09.003","volume":"1","author":"Trujillo J.","year":"2013","unstructured":"Trujillo J.; Chirino Y.I.; Jij\u00f3n M.E.; Romero A.A.C.; Tapia E.; Chaverr\u00ed P.J.; Renoprotective effect of the antioxidant curcumin: Recent findings. Redox Biol  2013,1(1),448-456","journal-title":"Redox Biol"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s43450-021-00175-0","volume":"31","author":"Devi A.","year":"2021","unstructured":"Devi A.; Dwibedi V.; Khan Z.A.; Natural antioxidants in new age-related diseases. Rev Bras Farmacogn  2021,31(4),387-407","journal-title":"Rev Bras Farmacogn"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"675287","DOI":"10.3389\/fphar.2021.675287","volume":"12","author":"Rattis B.A.C.","year":"2021","unstructured":"Rattis B.A.C.; Ramos S.G.; Celes M.R.N.; Curcumin as a potential treatment for COVID-19. Front Pharmacol  2021,12,675287","journal-title":"Front Pharmacol"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.1002\/fsn3.1858","volume":"8","author":"Babaei F.","year":"2020","unstructured":"Babaei F.; Asl N.M.; Hosseinzadeh H.; Curcumin (a constituent of turmeric): New treatment option against COVID\u201019. Food Sci Nutr  2020,8(10),5215-5227","journal-title":"Food Sci Nutr"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"173551","DOI":"10.1016\/j.ejphar.2020.173551","volume":"886","author":"Soni V.K.","year":"2020","unstructured":"Soni V.K.; Mehta A.; Ratre Y.K.; Tiwari A.K.; Amit A.; Singh R.P.; Sonkar S.C.; Chaturvedi N.; Shukla D.; Vishvakarma N.K.; Curcumin, a traditional spice component, can hold the promise against COVID-19? Eur J Pharmacol  2020,886,173551","journal-title":"Eur J Pharmacol"},{"key":"ref=166","first-page":"179","volume":"45","author":"Paz G.LA","year":"2020","unstructured":"Paz G.LA; Lossada CA; Moncayo LS; Romero F; Paz J; Villalobos V.J; P\u00e9rez AE; Blas S.E; Alvarado YJ; Theoretical molecular docking study of the structural disruption of the viral 3cl-protease of COVID19 induced by binding of capsaicin, piperine and curcumin part 1: A comparative study with chloroquine and hydrochloroquine two antimalaric drugs Res Square  2020,45,179-199","journal-title":"Res Square"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1080\/07391102.2020.1835719","volume":"40","author":"Emirik M.","year":"2022","unstructured":"Emirik M.; Potential therapeutic effect of turmeric contents against SARS-CoV-2 compared with experimental COVID-19 therapies: In silico study. J Biomol Struct Dyn  2022,40(5),2024-2037","journal-title":"J Biomol Struct Dyn"},{"key":"ref=168","first-page":"179","volume":"445","author":"Khaerunnisa S.","year":"2020","unstructured":"Khaerunnisa S.; Kurniawan H.; Awaluddin R.; Suhartati S.; Soetjipto S.; Potential inhibitor of COVID-19 main protease (Mpro) from several medicinal plant compounds by molecular docking study. Preprints Org  2020,445,179-199","journal-title":"Preprints Org"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1186\/s13063-020-04824-y","volume":"21","author":"Hassaniazad M.","year":"2020","unstructured":"Hassaniazad M.; Inchehsablagh B.R.; Kamali H.; Tousi A.; Eftekhar E.; Jaafari M.R.; Fathalipour M.; Sahlabadi N.S.; Gouklani H.; Alizade H.; Nikpoor A.R.; The clinical effect of Nano micelles containing curcumin as a therapeutic supplement in patients with COVID-19 and the immune responses balance changes following treatment: A structured summary of a study protocol for a randomised controlled trial. Trials  2020,21(1),876","journal-title":"Trials"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"O\u2019Boyle N.M.","year":"2011","unstructured":"O\u2019Boyle N.M.; Banck M.; James C.A.; Morley C.; Vandermeersch T.; Hutchison G.R.; Open Babel: An open chemical toolbox. J Cheminform  2011,3(1),33","journal-title":"J Cheminform"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","volume":"19","author":"Morris G.M.","year":"1998","unstructured":"Morris G.M.; Goodsell D.S.; Halliday R.S.; Huey R.; Hart W.E.; Belew R.K.; Olson A.J.; Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem  1998,19(14),1639-1662","journal-title":"J Comput Chem"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"161","DOI":"10.4172\/2167-0412.1000161","volume":"3","author":"Damanhouri Z.A.","year":"2014","unstructured":"Damanhouri Z.A.; Ahmad A.; A review on therapeutic potential of Piper nigrum L. (Black pepper): The king of spices. Med Aromat Plants  2014,3(3),161","journal-title":"Med Aromat Plants"},{"key":"ref=173","first-page":"4089","volume":"9","author":"Joshi D.R.","year":"2018","unstructured":"Joshi D.R.; Shrestha A.C.; Adhikari N.; A review on diversified use of the king of spices: Piper nigrum (black pepper). IJPSR  2018,9,4089-4101","journal-title":"IJPSR"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1007\/s00262-023-03487-3","volume":"72","author":"Lasso P.","year":"2023","unstructured":"Lasso P.; Rojas L.; Ar\u00e9valo C.; Urue\u00f1a C.; Murillo N.; Nossa P.; Sandoval T.; Chitiva L.C.; Barreto A.; Costa G.M.; Fiorentino S.; Piper nigrum extract suppresses tumor growth and enhances the antitumor immune response in murine models of breast cancer and melanoma. Cancer Immunol Immunother  2023,72(10),3279-3292","journal-title":"Cancer Immunol Immunother"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.joim.2018.07.002","volume":"16","author":"Sethiya N.K.","year":"2018","unstructured":"Sethiya N.K.; Ahmed N.M.; Shekh R.M.; Kumar V.; Singh K.P.; Kumar V.; Ethnomedicinal, phytochemical and pharmacological updates on Hygrophila auriculata (Schum.) Hiene: An overview. J Integr Med  2018,16(5),299-311","journal-title":"J Integr Med"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jep.2014.12.033","volume":"162","author":"Chander M.P.","year":"2015","unstructured":"Chander M.P.; Kartick C.; Vijayachari P.; Ethnomedicinal knowledge among Karens of Andaman and Nicobar Islands, India. J Ethnopharmacol  2015,162,127-133","journal-title":"J Ethnopharmacol"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.jep.2013.10.062","volume":"151","author":"Bhat P.","year":"2014","unstructured":"Bhat P.; Hegde G.R.; Hegde G.; Mulgund G.S.; Ethnomedicinal plants to cure skin diseases: An account of the traditional knowledge in the coastal parts of Central Western Ghats, Karnataka, India. J Ethnopharmacol  2014,151(1),493-502","journal-title":"J Ethnopharmacol"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.jep.2016.04.017","volume":"186","author":"Esakkimuthu S.","year":"2016","unstructured":"Esakkimuthu S.; Mutheeswaran S.; Arvinth S.; Paulraj M.G.; Pandikumar P.; Ignacimuthu S.; Quantitative ethnomedicinal survey of medicinal plants given for cardiometabolic diseases by the non-institutionally trained siddha practitioners of Tiruvallur district, Tamil Nadu, India. J Ethnopharmacol  2016,186,329-342","journal-title":"J Ethnopharmacol"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.eujim.2017.04.006","volume":"12","author":"Sureshkumar J.","year":"2017","unstructured":"Sureshkumar J.; Silambarasan R.; Ayyanar M.; An ethnopharmacological analysis of medicinal plants used by the Adiyan community in Wayanad district of Kerala, India. Eur J Integr Med  2017,12,60-73","journal-title":"Eur J Integr Med"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1002\/ptr.4972","volume":"27","author":"Meghwal M.","year":"2013","unstructured":"Meghwal M.; Goswami T.K.; Piper nigrum and piperine: An update. Phytother Res  2013,27(8),1121-1130","journal-title":"Phytother Res"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3390\/suschem4010005","volume":"4","author":"Lwamba C.","year":"2023","unstructured":"Lwamba C.; Aboushanab S.A.; Ambati R.R.; Kovaleva E.G.; Innovative green approach for extraction of piperine from black pepper based on response surface methodology. Sustain Chem  2023,4(1),40-53","journal-title":"Sustain Chem"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jpba.2015.06.027","volume":"115","author":"Di X.","year":"2015","unstructured":"Di X.; Wang X.; Di X.; Liu Y.; Effect of piperine on the bioavailability and pharmacokinetics of emodin in rats. J Pharm Biomed Anal  2015,115,144-149","journal-title":"J Pharm Biomed Anal"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"865","DOI":"10.2174\/1570180819999220204110306","volume":"19","author":"Vanshita","year":"2022","unstructured":"Vanshita ; Garg A.; Dewangan H.K.; Recent advances in drug design and delivery across biological barriers using computational models. Lett Drug Des Discov  2022,19(10),865-876","journal-title":"Lett Drug Des Discov"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"104580","DOI":"10.1016\/j.jddst.2023.104580","volume":"86","author":"Mishra A.K.","year":"2023","unstructured":"Mishra A.K.; Neha S.L.; Rani L.; Jain A.; Dewangan H.K.; Sahoo P.K.; Rationally designed nanoparticulate delivery approach for silymarin with natural bio-enhancer: In vitro characterization and in vivo evaluations of hepatoprotective effects in a mouse model. J Drug Deliv Sci Technol  2023,86,104580","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=185","first-page":"131","volume":"23","author":"Gbadamosi I.T.","year":"2020","unstructured":"Gbadamosi I.T.; Stay safe: Helpful herbal remedies in COVID-19 infection. Afr J Biomed Res  2020,23,131-133","journal-title":"Afr J Biomed Res"},{"key":"ref=186","doi-asserted-by":"publisher","first-page":"e00620","DOI":"10.1016\/j.sciaf.2020.e00620","volume":"10","author":"Orisakwe O.E.","year":"2020","unstructured":"Orisakwe O.E.; Orish C.N.; Nwanaforo E.O.; Coronavirus disease (COVID-19) and Africa: Acclaimed home remedies. Sci Afr  2020,10,e00620","journal-title":"Sci Afr"},{"key":"ref=187","doi-asserted-by":"publisher","first-page":"669362","DOI":"10.3389\/fphar.2021.669362","volume":"12","author":"Pawar K.S.","year":"2021","unstructured":"Pawar K.S.; Mastud R.N.; Pawar S.K.; Pawar S.S.; Bhoite R.R.; Bhoite R.R.; Kulkarni M.V.; Deshpande A.R.; Oral curcumin with piperine as adjuvant therapy for the treatment of COVID-19: a randomized clinical trial. Front Pharmacol  2021,12,669362","journal-title":"Front Pharmacol"},{"key":"ref=188","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1159\/000514204","volume":"182","author":"Bousquet J","year":"2020","unstructured":"Bousquet J; Czarlewski W; Zuberbier T; Mullol J; Blain H; Torre l.d.R; Anto JM; Induced cough challenges in a single patient with COVID-19 showing an interplay between Nrf2, TRPA1 and TRPV1 agonists. Int Arch Allergy Immunol  2020,182(4),324-338","journal-title":"Int Arch Allergy Immunol"},{"key":"ref=189","first-page":"179","volume":"45","author":"Mishra A","year":"2020","unstructured":"Mishra A; Pathak Y; Tripathi V; Natural compounds as potential inhibitors of novel coronavirus (COVID-19) main protease: An in silico study. Res Square  2020,45,179-199","journal-title":"Res Square"},{"key":"ref=190","doi-asserted-by":"publisher","first-page":"13696","DOI":"10.1080\/07391102.2023.2193987","volume":"41","author":"Amperayani K.R.","year":"2023","unstructured":"Amperayani K.R.; Varadhi G.; Oruganti B.; Parimi U.D.; Molecular dynamics and absolute binding free energy studies of piperine derivatives as potential inhibitors of SARS-CoV-2 main protease. J Biomol Struct Dyn  2023,41(23),13696-13706","journal-title":"J Biomol Struct Dyn"},{"key":"ref=191","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1186\/s12885-021-08520-1","volume":"21","author":"Gao S.","year":"2021","unstructured":"Gao S.; Gang J.; Yu M.; Xin G.; Tan H.; Computational analysis for identification of early diagnostic biomarkers and prognostic biomarkers of liver cancer based on GEO and TCGA databases and studies on pathways and biological functions affecting the survival time of liver cancer. BMC Canc  2021,21(1),791","journal-title":"BMC Canc"},{"key":"ref=192","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1080\/07391102.2020.1819879","volume":"40","author":"Rout J.","year":"2022","unstructured":"Rout J.; Swain B.C.; Tripathy U.; In silico investigation of spice molecules as potent inhibitor of SARS-CoV-2. J Biomol Struct Dyn  2022,40(2),860-874","journal-title":"J Biomol Struct Dyn"},{"key":"ref=193","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/02652048.2022.2051625","volume":"39","author":"Dewangan H.K.","year":"2022","unstructured":"Dewangan H.K.; Singh N.; Megh K.S.; Singh S.; Lakshmi ; Optimisation and evaluation of Gymnema sylvestre extract loaded polymeric nanoparticles for enhancement of in vivo efficacy and reduction of toxicity. J Microencapsul  2022,39(2),125-135","journal-title":"J Microencapsul"},{"key":"ref=194","doi-asserted-by":"publisher","first-page":"70","DOI":"10.5530\/srp.2018.1.14","volume":"9","author":"Tiwari P.","year":"2018","unstructured":"Tiwari P.; Nayak P.; Prusty S.K.; Sahu P.K.; Phytochemistry and pharmacology of tinospora cordifolia: A review. Syst Rev Pharm  2018,9(1),70-78","journal-title":"Syst Rev Pharm"},{"key":"ref=195","first-page":"57","volume":"10","author":"Gupta A.","year":"2021","unstructured":"Gupta A.; Pant C.H.; Singh N.; Saini N.; Mishra A.; Tomar H.; Potential role of Giloy (an important traditional Aurvedic medicinal dioecious creeper) as an immunomodulator. Adalya  2021,10,57-67","journal-title":"Adalya"},{"key":"ref=196","doi-asserted-by":"publisher","first-page":"38","DOI":"10.4103\/0974-8520.100307","volume":"33","author":"Vyas P.","year":"2012","unstructured":"Vyas P.; Ghanchi F.; Chandola H.M.; Ranthem S.; Clinical evaluation of Rasayana compound as an adjuvant in the management of tuberculosis with anti-Koch\u2032s treatment. Ayu  2012,33(1),38-43","journal-title":"Ayu"},{"key":"ref=197","doi-asserted-by":"publisher","first-page":"e02437","DOI":"10.1016\/j.heliyon.2019.e02437","volume":"5","author":"Sharma P.","year":"2019","unstructured":"Sharma P.; Dwivedee B.P.; Bisht D.; Dash A.K.; Kumar D.; The chemical constituents and diverse pharmacological importance of Tinospora cordifolia. Heliyon  2019,5(9),e02437","journal-title":"Heliyon"},{"key":"ref=198","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1007\/s11030-023-10684-w","volume":"28","author":"Bisht A.","year":"2023","unstructured":"Bisht A.; Tewari D.; Kumar S.; Chandra S.; Network pharmacology, molecular docking, and molecular dynamics simulation to elucidate the mechanism of anti-aging action of Tinospora cordifolia. Mol Divers  2023,28(3),1743-1763","journal-title":"Mol Divers"},{"key":"ref=199","first-page":"990","volume":"10","author":"Nandkumar T.V.","year":"2021","unstructured":"Nandkumar T.V.; Dinkar T.A.; Popat M.S.; Mohan D.D.; A review on Tinospora cordifolia immunity booster. World J Pharm Res  2021,10(5),990-1006","journal-title":"World J Pharm Res"},{"key":"ref=200","doi-asserted-by":"publisher","first-page":"151","DOI":"10.4103\/0257-7941.107344","volume":"31","author":"Ghosh S.","year":"2012","unstructured":"Ghosh S.; Saha S.; Tinospora cordifolia: One plant, many roles. Anc Sci Life  2012,31(4),151-159","journal-title":"Anc Sci Life"},{"key":"ref=201","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13205-021-02685-z","volume":"11","author":"Manne M","year":"2021","unstructured":"Manne M; Goudar G; Varikasuvu SR; Khetagoudar MC; Kanipakam H; Natarajan P; Ummiti MD; Yenagi VA; Chinthakindi S; Dharani P; Thota DSS; Patil S; Patil V; Cordifolioside: Potent inhibitor against Mpro of SARS-CoV-2 and immunomodulatory through human TGF-\u03b2 and TNF-\u03b1. 3 Biotech  2021,11,1-25","journal-title":"3 Biotech"},{"key":"ref=202","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1080\/09205063.2022.2155782","volume":"34","author":"Yadav D.","year":"2023","unstructured":"Yadav D.; Semwal B.C.; Dewangan H.K.; Grafting, characterization and enhancement of therapeutic activity of berberine loaded PEGylated PAMAM dendrimer for cancerous cell. J Biomater Sci Polym Ed  2023,34(8),1053-1066","journal-title":"J Biomater Sci Polym Ed"},{"key":"ref=203","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3390\/molecules26010085","volume":"26","author":"Kochman J.","year":"2020","unstructured":"Kochman J.; Jakubczyk K.; Antoniewicz J.; Mruk H.; Janda K.; Health benefits and chemical composition of matcha green tea: a review. Molecules  2020,26(1),85","journal-title":"Molecules"},{"key":"ref=204","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/hep.24803","volume":"55","author":"Calland N","year":"2012","unstructured":"Calland N; Albecka A; Belouzard S; Wychowski C; Duverlie G; Descamps V; Hober D; Dubuisson J; Rouill\u00e9 Y; S\u00e9ron KJH; S\u00e9ron KJH. (\u2212)\u2010Epigallocatechin\u20103\u2010gallate is a new inhibitor of hepatitis C virus entry. Hepatology  2012,55(3),720-729","journal-title":"Hepatology"},{"key":"ref=205","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1097\/00002030-200204120-00020","volume":"16","author":"Fassina G","year":"2002","unstructured":"Fassina G; Buffa A; Benelli R; Varnier OE; Noonan DM; Albini AJA; Polyphenolic antioxidant (\u2013)-epigallocatechin-3-gallate from green tea as a candidate anti-HIV agent. AIDS  2002,16(6),939-941","journal-title":"AIDS"},{"key":"ref=206","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.2174\/0929867324666161123091010","volume":"23","author":"Ide K","year":"2016","unstructured":"Ide K; Kawasaki Y; Kawakami K; Anti influenza virus effects of catechins: A molecular and clinical review. Curr Med Chem  2016,23(42),4773-4783","journal-title":"Curr Med Chem"},{"key":"ref=207","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/BF02978215","volume":"28","author":"Lyu S-Y","year":"2005","unstructured":"Lyu S-Y; Rhim J-Y; Antiherpetic activities of flavonoids against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in vitro. Arch Pharm Res  2005,28(11),1293-1301","journal-title":"Arch Pharm Res"},{"key":"ref=208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2014.11.001","volume":"113","author":"Weber C","year":"2015","unstructured":"Weber C; Sliva K; Rhein v.C; K\u00fcmmerer BM; The green tea catechin, epigallocatechin gallate inhibits chikungunya virus infection. Antiviral Res  2015,113,1-3","journal-title":"Antiviral Res"},{"key":"ref=209","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.virol.2016.06.012","volume":"496","author":"Carneiro BM","year":"2016","unstructured":"Carneiro BM; Batista MN; Braga ACS; Nogueira ML; Rahal PJV; The green tea molecule EGCG inhibits Zika virus entry. Virology  2016,496,215-218","journal-title":"Virology"},{"key":"ref=210","doi-asserted-by":"publisher","first-page":"3962","DOI":"10.3390\/molecules26133962","volume":"26","author":"Wang Y.Q.","year":"2021","unstructured":"Wang Y.Q.; Li Q.S.; Zheng X.Q.; Lu J.L.; Liang Y.R.; Antiviral effects of green tea EGCG and its potential application against COVID-19. Molecules  2021,26(13),3962","journal-title":"Molecules"},{"key":"ref=211","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1186\/s13063-021-05462-8","volume":"22","author":"Mahmoodi S.","year":"2021","unstructured":"Mahmoodi S.; Yousefi M.; Sadeghi O.; Mahmoodabadi A.; Sadriirani M.; Hosseinzade Z.; Jahanbakhsh A.; Panahande S.B.; Saeedinejad Z.; Malekzadeh J.M.; Naghmachi M.; Pourmahmoudi A.; Green tea intake and its effect on laboratory parameters and disease symptoms in hospitalised patients with COVID 19: A structured protocol for a randomized controlled trial. Trials  2021,22(1),514","journal-title":"Trials"},{"key":"ref=212","doi-asserted-by":"publisher","first-page":"001574","DOI":"10.1099\/jgv.0.001574","volume":"102","author":"Henss L.","year":"2021","unstructured":"Henss L.; Auste A.; Sch\u00fcrmann C.; Schmidt C.; Rhein V.C.; M\u00fchlebach M.D.; Schnierle B.S.; The green tea catechin epigallocatechin gallate inhibits SARS-CoV-2 infection. J Gen Virol  2021,102(4),001574","journal-title":"J Gen Virol"},{"key":"ref=213","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bbrc.2021.02.016","volume":"547","author":"Jang M.","year":"2021","unstructured":"Jang M.; Park R.; Park Y.I.; Cha Y.E.; Yamamoto A.; Lee J.I.; Park J.; EGCG, a green tea polyphenol, inhibits human coronavirus replication in vitro. Biochem Biophys Res Commun  2021,547,23-28","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=214","doi-asserted-by":"publisher","first-page":"3572","DOI":"10.3390\/molecules26123572","volume":"16","author":"Ohgitani E.","year":"2020","unstructured":"Ohgitani E.; Ya S.M.; Ichitani M.; Kobayashi M.; Takihara T.; Kawamoto M.; Kinugasa H.; Mazda O.; Significant inactivation of SARS-CoV-2 by a green tea catechin, a catechin-derivative and galloylated theaflavins in vitro. Molecules  2020,16(12),3572","journal-title":"Molecules"},{"key":"ref=215","doi-asserted-by":"publisher","first-page":"4362","DOI":"10.1080\/07391102.2020.1779818","volume":"39","author":"Ghosh R.","year":"2021","unstructured":"Ghosh R.; Chakraborty A.; Biswas A.; Chowdhuri S.; Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors: An in silico docking and molecular dynamics simulation study. J Biomol Struct Dyn  2021,39(12),4362-4374","journal-title":"J Biomol Struct Dyn"},{"key":"ref=216","doi-asserted-by":"publisher","first-page":"601316","DOI":"10.3389\/fpls.2020.601316","volume":"11","author":"Zhu Y.","year":"2020","unstructured":"Zhu Y.; Xie D.Y.; Docking characterization and in vitro inhibitory activity of flavan-3-ols and dimeric proanthocyanidins against the main protease activity of SARS-Cov-2. Front Plant Sci  2020,11,601316","journal-title":"Front Plant Sci"},{"key":"ref=217","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.1080\/07391102.2020.1766572","volume":"39","author":"Bhardwaj V.K.","year":"2021","unstructured":"Bhardwaj V.K.; Singh R.; Sharma J.; Rajendran V.; Purohit R.; Kumar S.; Identification of bioactive molecules from tea plant as SARS-CoV-2 main protease inhibitors. J Biomol Struct Dyn  2021,39(10),3449-3458","journal-title":"J Biomol Struct Dyn"},{"key":"ref=218","doi-asserted-by":"publisher","first-page":"1213052","DOI":"10.3389\/fphar.2023.1213052","volume":"14","author":"Kamel F.O.","year":"2023","unstructured":"Kamel F.O.; Karim S.; Bafail D.A.O.; Aldawsari H.M.; Kotta S.; Ilyas U.K.; Hepatoprotective effects of bioactive compounds from traditional herb Tulsi (Ocimum sanctum Linn) against galactosamine-induced hepatotoxicity in rats. Front Pharmacol  2023,14,1213052","journal-title":"Front Pharmacol"},{"key":"ref=219","doi-asserted-by":"publisher","first-page":"205","DOI":"10.31254\/phyto.2016.5507","volume":"5","author":"Verma S.","year":"2016","unstructured":"Verma S.; Chemical constituents and pharmacological action of Ocimum sanctum (Indian holy basil-Tulsi). J Phyto  2016,5(5),205-207","journal-title":"J Phyto"},{"key":"ref=220","first-page":"265258","volume":"3","author":"Borah R.","year":"2018","unstructured":"Borah R.; Biswas S.P.; Tulsi (Ocimum sanctum), excellent source of phytochemicals. Int J Environ Agric Biotechnol  2018,3(5),265258","journal-title":"Int J Environ Agric Biotechnol"},{"key":"ref=221","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3109\/13880209.2010.521513","volume":"49","author":"Monga J.","year":"2011","unstructured":"Monga J.; Sharma M.; Tailor N.; Ganesh N.; Antimelanoma and radioprotective activity of alcoholic aqueous extract of different species of Ocimum in C  BL mice. Pharm Biol  2011,49(4),428-436","journal-title":"Pharm Biol"},{"key":"ref=222","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s12291-016-0615-4","volume":"32","author":"Satapathy S.","year":"2017","unstructured":"Satapathy S.; Das N.; Bandyopadhyay D.; Mahapatra S.C.; Sahu D.S.; Meda M.; Effect of Tulsi (Ocimum sanctum Linn.) supplementation on metabolic parameters and liver enzymes in young overweight and obese subjects. Indian J Clin Biochem  2017,32(3),357-363","journal-title":"Indian J Clin Biochem"},{"key":"ref=223","first-page":"11","volume":"6","author":"Kumar A.H.","year":"2020","unstructured":"Kumar A.H.; Molecular docking of natural compounds from tulsi (Ocimum sanctum) and neem (Azadirachta indica) against SARS-CoV-2 protein targets. Biology, Engineering. Medicine and Science Reports  2020,6,11-13","journal-title":"Medicine and Science Reports"},{"key":"ref=224","doi-asserted-by":"publisher","first-page":"435","DOI":"10.26434\/chemrxiv.12599915.v1","volume":"41","author":"Mohapatra PK","year":"2020","unstructured":"Mohapatra PK; Chopdar KS; Dash GC; Raval MK; In silico screening of phytochemicals of Ocimum sanctum against main protease of SARS-CoV-2. J Biomol Struct Dyn  2020,41(2),435-444","journal-title":"J Biomol Struct Dyn"},{"key":"ref=225","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s12539-016-0157-8","volume":"9","author":"Ismail N.A.","year":"2017","unstructured":"Ismail N.A.; Jusoh S.A.; Molecular docking and molecular dynamics simulation studies to predict flavonoid binding on the surface of DENV2 E protein. Interdiscip Sci  2017,9(4),499-511","journal-title":"Interdiscip Sci"},{"key":"ref=226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13721-019-0207-3","volume":"9","author":"Mahajan P.","year":"2020","unstructured":"Mahajan P.; Tomar S.; Kumar A.; Yadav N.; Arya A.; Dwivedi V.D.; A multi-target approach for discovery of antiviral compounds against dengue virus from green tea. Netw Model Anal Health Inform Bioinform  2020,9,1-10","journal-title":"Netw Model Anal Health Inform Bioinform"},{"key":"ref=227","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s43094-020-00126-x","volume":"6","author":"Rajagopal K.","year":"2020","unstructured":"Rajagopal K.; Varakumar P.; Baliwada A.; Byran G.; Activity of phytochemical constituents of Curcuma longa (turmeric) and Andrographis paniculata against coronavirus (COVID-19): An in silico approach. Future J Pharm Sci  2020,6(1),104","journal-title":"Future J Pharm Sci"},{"key":"ref=228","doi-asserted-by":"publisher","first-page":"912","DOI":"10.3389\/fmicb.2019.00912","volume":"10","author":"Praditya D.","year":"2019","unstructured":"Praditya D.; Kirchhoff L.; Br\u00fcning J.; Rachmawati H.; Steinmann J.; Steinmann E.; Anti-infective properties of the golden spice curcumin. Front Microbiol  2019,10,912-912","journal-title":"Front Microbiol"},{"key":"ref=229","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s12013-015-0524-9","volume":"72","author":"Cai Z.","year":"2015","unstructured":"Cai Z.; Zhang G.; Tang B.; Liu Y.; Fu X.; Zhang X.; Promising anti-influenza properties of active constituent of withania somnifera ayurvedic herb in targeting neuraminidase of H1N1 influenza: computational study. Cell Biochem Biophys  2015,72(3),727-739","journal-title":"Cell Biochem Biophys"},{"key":"ref=230","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/ptr.6024","volume":"32","author":"Akram M.","year":"2018","unstructured":"Akram M.; Tahir I.M.; Shah S.M.A.; Mahmood Z.; Altaf A.; Ahmad K.; Munir N.; Daniyal M.; Nasir S.; Mehboob H.; Antiviral potential of medicinal plants against HIV, HSV, influenza, hepatitis, and coxsackievirus: A systematic review. Phytother Res  2018,32(5),811-822","journal-title":"Phytother Res"},{"key":"ref=231","doi-asserted-by":"publisher","first-page":"S1945","DOI":"10.1016\/S2221-1691(12)60524-3","volume":"2","author":"Ahmad N.","year":"2012","unstructured":"Ahmad N.; Fazal H.; Abbasi B.H.; Farooq S.; Ali M.; Khan M.A.; Biological role of Piper nigrum L. (Black pepper): A review. Asian Pac J Trop Biomed  2012,2(3),S1945-S1953","journal-title":"Asian Pac J Trop Biomed"},{"key":"ref=232","doi-asserted-by":"publisher","first-page":"e0241739","DOI":"10.1371\/journal.pone.0241739","volume":"15","author":"Roshdy W.H.","year":"2020","unstructured":"Roshdy W.H.; Rashed H.A.; Kandeil A.; Mostafa A.; Moatasim Y.; Kutkat O.; Shama A.N.M.; Gomaa M.R.; Sayed E.I.H.; Guindy E.N.M.; Naguib A.; Kayali G.; Ali M.A.; EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2. PLoS One  2020,15(11),e0241739","journal-title":"PLoS One"},{"key":"ref=233","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.2174\/1389201021666200430114547","volume":"21","author":"Kumar P.","year":"2020","unstructured":"Kumar P.; Kamle M.; Mahato D.K.; Bora H.; Sharma B.; Rasane P.; Bajpai V.K.; Tinospora cordifolia (Giloy): Phytochemistry, ethnopharmacology, clinical application and conservation strategies. Curr Pharm Biotechnol  2020,21(12),1165-1175","journal-title":"Curr Pharm Biotechnol"},{"key":"ref=234","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s13659-020-00250-4","volume":"10","author":"Orhan I.E.","year":"2020","unstructured":"Orhan I.E.; Deniz S.F.S.; Natural products as potential leads against coronaviruses: Could they be encouraging structural models against SARS-CoV-2? Nat Prod Bioprospect  2020,10(4),171-186","journal-title":"Nat Prod Bioprospect"},{"key":"ref=235","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1080\/20415990.2024.2380239","volume":"15","author":"Sharma A.N.","year":"2024","unstructured":"Sharma A.N.; Upadhyay P.K.; Dewangan H.K.; Dual combination of resveratrol and pterostilbene aqueous core nanocapsules for integrated prostate cancer targeting. Ther Deliv  2024,15(9),685-698","journal-title":"Ther Deliv"},{"key":"ref=236","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1080\/07391102.2020.1813630","volume":"40","author":"Oso B.J.","year":"2022","unstructured":"Oso B.J.; Adeoye A.O.; Olaoye I.F.; Pharmacoinformatics and hypothetical studies on allicin, curcumin, and gingerol as potential candidates against COVID-19-associated proteases. J Biomol Struct Dyn  2022,40(1),389-400","journal-title":"J Biomol Struct Dyn"},{"key":"ref=237","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3109\/14756366.2014.1003215","volume":"31","author":"Park J.Y.","year":"2016","unstructured":"Park J.Y.; Ko J.A.; Kim D.W.; Kim Y.M.; Kwon H.J.; Jeong H.J.; Kim C.Y.; Park K.H.; Lee W.S.; Ryu Y.B.; Chalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS-CoV. J Enzyme Inhib Med Chem  2016,31(1),23-30","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=238","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3109\/14756366.2012.753591","volume":"29","author":"Kim D.W.","year":"2014","unstructured":"Kim D.W.; Seo K.H.; Long C.M.J.; Oh K.Y.; Oh J.W.; Cho J.K.; Lee K.H.; Park K.H.; Phenolic phytochemical displaying SARS-CoV papain-like protease inhibition from the seeds of Psoralea corylifolia. J Enzyme Inhib Med Chem  2014,29(1),59-63","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=239","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2478\/bile-2020-0002","volume":"57","author":"Sawikowska A.","year":"2020","unstructured":"Sawikowska A.; Meta-analysis of flavonoids with antiviral potential against coronavirus. Biom Lett  2020,57(1),13-22","journal-title":"Biom Lett"},{"key":"ref=240","doi-asserted-by":"publisher","first-page":"561334","DOI":"10.3389\/fphar.2020.561334","volume":"11","author":"Verma S.","year":"2020","unstructured":"Verma S.; Twilley D.; Esmear T.; Oosthuizen C.B.; Reid A.M.; Nel M.; Lall N.; Anti-SARS-CoV natural products with the potential to inhibit SARS-CoV-2 (COVID-19). Front Pharmacol  2020,11,561334","journal-title":"Front Pharmacol"},{"key":"ref=241","doi-asserted-by":"publisher","first-page":"197989","DOI":"10.1016\/j.virusres.2020.197989","volume":"284","author":"Mani J.S.","year":"2020","unstructured":"Mani J.S.; Johnson J.B.; Steel J.C.; Broszczak D.A.; Neilsen P.M.; Walsh K.B.; Naiker M.; Natural product-derived phytochemicals as potential agents against coronaviruses: A review. Virus Res  2020,284,197989","journal-title":"Virus Res"},{"key":"ref=242","doi-asserted-by":"publisher","first-page":"153311","DOI":"10.1016\/j.phymed.2020.153311","volume":"85","author":"Khalifa S.A.M.","year":"2021","unstructured":"Khalifa S.A.M.; Yosri N.; Mallah E.M.F.; Ghonaim R.; Guo Z.; Musharraf S.G.; Du M.; Khatib A.; Xiao J.; Saeed A.; Seedi E.H.H.R.; Zhao C.; Efferth T.; Seedi E.H.R.; Screening for natural and derived bio-active compounds in preclinical and clinical studies: One of the frontlines of fighting the coronaviruses pandemic. Phytomedicine  2021,85,153311","journal-title":"Phytomedicine"},{"key":"ref=243","doi-asserted-by":"publisher","first-page":"3936","DOI":"10.3390\/molecules25173936","volume":"25","author":"Rakib A.","year":"2020","unstructured":"Rakib A.; Paul A.; Chy M.N.U.; Sami S.A.; Baral S.K.; Majumder M.; Tareq A.M.; Amin M.N.; Shahriar A.; Uddin M.Z.; Dutta M.; Tallei T.E.; Emran T.B.; Gandara S.J.; Biochemical and computational approach of selected phytocompounds from tinospora crispa in the management of COVID-19. Molecules  2020,25(17),3936","journal-title":"Molecules"},{"key":"ref=244","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/pca.1102","volume":"20","author":"P\u00fcssa T.","year":"2009","unstructured":"P\u00fcssa T.; Raudsepp P.; Kuzina K.; Raal A.; Polyphenolic composition of roots and petioles of Rheum rhaponticum L. Phytochem Anal  2009,20(2),98-103","journal-title":"Phytochem Anal"},{"key":"ref=245","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3839\/jabc.2011.012","volume":"54","author":"Park J.H.","year":"2011","unstructured":"Park J.H.; Wu Q.; Yoo K.H.; Yong H.I.; Cho S.M.; Chung I.S.; Baek N.I.; Cytotoxic effect of flavonoids from the roots of Glycyrrhiza uralensis on human cancer cell lines. J Appl Biol Chem  2011,54(1),67-70","journal-title":"J Appl Biol Chem"},{"key":"ref=246","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1007\/s11164-018-03727-7","volume":"45","author":"Sathya B.","year":"2019","unstructured":"Sathya B.; Prasath M.; Spectroscopic (FT-IR, FT-Raman, UV\u2013Vis), quantum chemical calculation and molecular docking evaluation of liquiritigenin: An influenza A (H1N1) neuraminidase inhibitor. Res Chem Intermed  2019,45(4),2135-2166","journal-title":"Res Chem Intermed"}],"container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113816128344055250220100720","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/240372\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113816128344055250220100720","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T05:23:13Z","timestamp":1754284993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/240372\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":246,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113816128344055250220100720","relation":{},"ISSN":["1381-6128"],"issn-type":[{"type":"print","value":"1381-6128"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-07-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}